This is a Validated Antibody Database (VAD) review about human OCLN, based on 357 published articles (read how Labome selects the articles), using OCLN antibody in all methods. It is aimed to help Labome visitors find the most suited OCLN antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
OCLN synonym: BLCPMG; PPP1R115; PTORCH1

Knockout validation
Invitrogen
mouse monoclonal (OC-3F10)
  • western blot knockout validation; human; fig 1
In order to determine the contribution of occludin to hepatitis C virus infection, Invitrogen OCLN antibody (Thermo Fisher, noca) was used in western blot knockout validation on human samples (fig 1). Biol Pharm Bull (2016) ncbi
Invitrogen
mouse monoclonal (OC-3F10)
  • immunocytochemistry; African green monkey; loading ...; fig 1a
Invitrogen OCLN antibody (Thermo Fisher, 33-1500) was used in immunocytochemistry on African green monkey samples (fig 1a). PLoS ONE (2022) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig 6a
Invitrogen OCLN antibody (Thermo Fisher, 33-1500) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 6a). elife (2021) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; African green monkey; 1:100; fig 1d
  • western blot; African green monkey; 1:5000; loading ...; fig 4c
  • western blot; rat; 1:5000; loading ...; fig 4c
Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry on African green monkey samples at 1:100 (fig 1d), in western blot on African green monkey samples at 1:5000 (fig 4c) and in western blot on rat samples at 1:5000 (fig 4c). Pharmaceutics (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:100; loading ...; fig 5a
Invitrogen OCLN antibody (Thermo Scientific, 40-4700) was used in western blot on human samples at 1:100 (fig 5a). Nat Commun (2021) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; loading ...; fig 7
Invitrogen OCLN antibody (Thermo Fisher Scientific, 33-1500) was used in immunohistochemistry on mouse samples (fig 7). Front Cell Infect Microbiol (2021) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; loading ...; fig 2e
Invitrogen OCLN antibody (Thermo Fisher, 33-1500) was used in western blot on mouse samples (fig 2e). Front Med (Lausanne) (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 9i
  • western blot; mouse; loading ...; fig 9b
Invitrogen OCLN antibody (Thermofisher, 71-1500) was used in western blot on human samples (fig 9i) and in western blot on mouse samples (fig 9b). J Biomed Sci (2021) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 4b
Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry on mouse samples at 1:100 (fig 4b). J Exp Med (2021) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; loading ...; fig 3c
Invitrogen OCLN antibody (Thermo Scientific, 33-1500) was used in immunohistochemistry on mouse samples (fig 3c). Neurotrauma Rep (2020) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 8e
Invitrogen OCLN antibody (Invitrogen, 331500) was used in immunohistochemistry on mouse samples at 1:50 (fig 8e). Acta Neuropathol (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 4f
Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in western blot on mouse samples (fig 4f). PLoS ONE (2020) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 2a
Invitrogen OCLN antibody (Invitrogen, 331500) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2a). Sci Rep (2020) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dogs; loading ...; fig 1d
  • immunocytochemistry; human; loading ...; fig 2e, 6g, s1a
  • immunohistochemistry; human; loading ...; fig 1b
Invitrogen OCLN antibody (ThermoFisher Scientific, 33-1500) was used in immunocytochemistry on dogs samples (fig 1d), in immunocytochemistry on human samples (fig 2e, 6g, s1a) and in immunohistochemistry on human samples (fig 1b). iScience (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:2000; loading ...; fig 6d
Invitrogen OCLN antibody (Zymed, 71-1500) was used in western blot on mouse samples at 1:2000 (fig 6d). Cell Mol Gastroenterol Hepatol (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s2b
Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in western blot on human samples (fig s2b). J Mol Cell Biol (2019) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 5b
Invitrogen OCLN antibody (Thermo Fisher, 33-1500) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 5b). elife (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 3f
Invitrogen OCLN antibody (Invitrogen, 406100) was used in immunohistochemistry on mouse samples (fig 3f). elife (2019) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; loading ...; fig 2d
Invitrogen OCLN antibody (Abcam, 33-1500) was used in immunohistochemistry on mouse samples (fig 2d). Cell Mol Gastroenterol Hepatol (2019) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:40; loading ...; fig s1b
Invitrogen OCLN antibody (Thermo Scientific, OC-3F10) was used in immunohistochemistry on human samples at 1:40 (fig s1b). Mol Hum Reprod (2019) ncbi
domestic rabbit monoclonal (6HCLC)
  • western blot; mouse; 1:500-1:1000; loading ...; fig 3
Invitrogen OCLN antibody (Thermo Fisher Scientific, 6HCLC) was used in western blot on mouse samples at 1:500-1:1000 (fig 3). Biol Pharm Bull (2018) ncbi
domestic rabbit polyclonal
  • western blot; rat; fig 2a
Invitrogen OCLN antibody (Zymed Laboratories, 71-1500) was used in western blot on rat samples (fig 2a). J Neurosci (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig s2g
Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in western blot on mouse samples (fig s2g). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 5g
In order to study the effect of angiocrine factors on retinal pigment epithelium basement membrane and barrier function, Invitrogen OCLN antibody (Thermo Fisher Scientific, 71-1500) was used in western blot on human samples at 1:1000 (fig 5g). Nat Commun (2017) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:100; fig 5l
In order to study the effect of angiocrine factors on retinal pigment epithelium basement membrane and barrier function, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry on human samples at 1:100 (fig 5l). Nat Commun (2017) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; 1:2000; loading ...; fig 3b
In order to describe a role for sphingosine 1-phosphate receptor-1 in regulating blood brain barrier permeability, Invitrogen OCLN antibody (Invitrogen, 331500) was used in western blot on mouse samples at 1:2000 (fig 3b). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; dogs; 1:200; loading ...; fig 7d
  • western blot; dogs; loading ...; fig 7e
In order to find and characterize the interaction between Eps15 and pS227-FIP2, Invitrogen OCLN antibody (BD Biosciences, 71-1500) was used in immunocytochemistry on dogs samples at 1:200 (fig 7d) and in western blot on dogs samples (fig 7e). Mol Biol Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 4f
In order to study meiotic germ cell antigens, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in western blot on mouse samples (fig 4f). J Clin Invest (2017) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; fig 2b
In order to investigate the role of nuclear factor erythroid 2-related factor in cigarette smoking-induced cerebrobvascular/blood brain barrier impairments, Invitrogen OCLN antibody (Life Technologies, 331500) was used in western blot on mouse samples (fig 2b). Redox Biol (2017) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; loading ...; fig 2a
In order to explore the responses of occludin to stimulation by TNFalpha, IL-1beta and LPS in an immortalized human cerebral endothelial cell line, Invitrogen OCLN antibody (Thermo Fisher Scientific, OC-3F10) was used in western blot on human samples (fig 2a). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; dogs; loading ...; fig 5a
In order to study the role of P-Glycoprotein in the tight junctions using MCDK cells., Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in immunocytochemistry on dogs samples (fig 5a). IEEE Trans Nanobioscience (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; loading ...; fig 4b
  • western blot; human; 1:1000; loading ...; tbl 3
In order to report the presence of PIWI-like proteins in somatic cells and the possible role of HIWI2 in preserving the functional integrity of epithelial cells, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig 4b) and in western blot on human samples at 1:1000 (tbl 3). Mol Cell Biochem (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:150; fig 6a
  • western blot; rat; 1:300; fig 6g
In order to elucidate how particulate matter impairs male reproduction, Invitrogen OCLN antibody (Invitrogen, 40-4700) was used in immunohistochemistry - paraffin section on rat samples at 1:150 (fig 6a) and in western blot on rat samples at 1:300 (fig 6g). Toxicol Lett (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; dogs; 1:50; loading ...; fig 7a
In order to assess changes in the cell and luminal volumes of type II Madin-Darby canine kidney cells grown in response to drugs or to changes in the composition of the basal extracellular fluid, Invitrogen OCLN antibody (Zymed, 71-1500) was used in immunocytochemistry on dogs samples at 1:50 (fig 7a). Can J Physiol Pharmacol (2017) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 4
In order to test if A2A receptor signaling governs the blood-brain barrier dynamics in sleep-restricted rats, Invitrogen OCLN antibody (Invitrogen, 40-4700) was used in western blot on rat samples at 1:1000 (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; 1:1000; loading ...; fig 6a
  • western blot; human; 1:1000; loading ...; fig 2a
In order to examine the role of Salmonella AvrA during infection, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in western blot on mouse samples at 1:1000 (fig 6a) and in western blot on human samples at 1:1000 (fig 2a). J Biol Chem (2016) ncbi
mouse monoclonal (OC-3F10)
  • western blot; domestic rabbit; 1:1000; loading ...; fig 6b
In order to investigate the role of TRPV4 in a corneal epithelial cell model, Invitrogen OCLN antibody (Thermo Fisher, 33-1511) was used in western blot on domestic rabbit samples at 1:1000 (fig 6b). J Cell Physiol (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 7c
In order to report the effects of peroxisome proliferator-activated receptor beta/delta agonist on the acute phase response after brain injury, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in western blot on mouse samples at 1:1000 (fig 7c). Transl Res (2017) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; loading ...; fig 1.1
In order to study how iron-depleted, iron-saturated, and manganese-saturated forms of lactoferrin govern intestinal barrier function, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunohistochemistry on human samples (fig 1.1). Biometals (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 5a
In order to assess the contribution of mutated prostasin in dextran sodium sulfate-induced colitis, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:1000 (fig 5a). Inflamm Bowel Dis (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; rat; 1:100; loading ...; fig 3c
In order to assess the effects of PEGylation on the toxicity of nanoparticles in rat brains, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in immunocytochemistry on rat samples at 1:100 (fig 3c). Mol Pharm (2016) ncbi
domestic rabbit monoclonal (6HCLC)
  • western blot; human; fig s1
In order to test if protein kinase D2 affects murine colitis, Invitrogen OCLN antibody (Invitrogen, 710192) was used in western blot on human samples (fig s1). Sci Rep (2016) ncbi
domestic rabbit monoclonal (6HCLC)
  • western blot; human; 1:1000; loading ...; fig 5a
In order to test if alpha-synuclein preformed fibrils alter endothelial function, Invitrogen OCLN antibody (Life Technologies, 710192) was used in western blot on human samples at 1:1000 (fig 5a). Exp Neurol (2016) ncbi
domestic rabbit recombinant (6H10L9)
  • western blot; pigs ; fig 6A
In order to assess the effects of deoxynivalenol and its derivatives on intestinal tight junction proteins, Invitrogen OCLN antibody (ThermoScientific, 6H10L9) was used in western blot on pigs samples (fig 6A). Toxins (Basel) (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 2.5 ug/ml; loading ...; fig 3d
In order to demonstrate a novel mechanism by which HIV-1 invades ocular tissues and promotes translocation or invasion by additional pathogens, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples at 2.5 ug/ml (fig 3d). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; dogs; 1:200; loading ...; fig 4a
  • western blot; dogs; 1:1000; loading ...; fig 3d
In order to measure tight junction protein expression in canine duodenum, lung, liver, and kidney, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on dogs samples at 1:200 (fig 4a) and in western blot on dogs samples at 1:1000 (fig 3d). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 7 ug/ml; loading ...; tbl s5
  • western blot; mouse; 3 ug/ml; loading ...; tbl s5
In order to explore the effects of mild chronic psychological stress on metabolic, inflammatory, and behavioral profiles in a mouse model of diet-induced obesity, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in immunohistochemistry on mouse samples at 7 ug/ml (tbl s5) and in western blot on mouse samples at 3 ug/ml (tbl s5). Brain Behav Immun (2017) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:250; loading ...; tbl 1
In order to examine the organization of actin microfilaments in Sertoli cell at the blood testis barrier, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:250 (tbl 1). Spermatogenesis (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:400; loading ...; fig 4l
In order to study the role of TLR4 in irinotecan-induced diarrhea, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in western blot on mouse samples at 1:400 (fig 4l). Mol Cancer Ther (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3a
In order to study the role of TLR4 in irinotecan-induced diarrhea, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3a). Mol Cancer Ther (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dogs; 1:200; fig 5
  • western blot; dogs; 1:1000; fig 8a
In order to investigate how serine proteases increase transepithelial electrical resistance, Invitrogen OCLN antibody (Invitrogen, 331500) was used in immunocytochemistry on dogs samples at 1:200 (fig 5) and in western blot on dogs samples at 1:1000 (fig 8a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 1
  • western blot; mouse; 1:1000; fig 1
  • western blot; rat; 1:1000; fig 1
In order to examine claudin-11 localization in testis of patients with normal and impaired spermatogenesis, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in western blot on human samples at 1:1000 (fig 1), in western blot on mouse samples at 1:1000 (fig 1) and in western blot on rat samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:100; loading ...
In order to propose using an integrated insert in a dynamic microfluidic platform for toxicological testing, Invitrogen OCLN antibody (Thermo Fisher, 33-1500) was used in immunocytochemistry on rat samples at 1:100. J Appl Toxicol (2017) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:250; fig 2
In order to characterize overexpression of gap junction protein connexin 43 by rescue of perfluorooctanesulfonate (PFOS)-mediated sertoli cell injury, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:250 (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; fig 3a
In order to test if hypoxia inducible factor-1 activation contributes to hyperglycemia-aggravated blood brain barrier disruption in an ischemic stroke model, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in western blot on mouse samples (fig 3a). Neurobiol Dis (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 2f
In order to examine trafficking of cancer-targeting alkylphosphocholine analogues across the blood brain barrier, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples at 1:200 (fig 2f). Mol Pharm (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; rat; 1:100; fig 2
In order to report that crumbs homolog 3 is an actin microfilament regulator, Invitrogen OCLN antibody (Invitrogen, Life Technologies, 33-1500) was used in immunohistochemistry - frozen section on rat samples at 1:100 (fig 2). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:250; fig 5
In order to report that crumbs homolog 3 is an actin microfilament regulator, Invitrogen OCLN antibody (Invitrogen, Life Technologies, 71-1500) was used in western blot on rat samples at 1:250 (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; 1:100; fig s8
In order to analyze preservation of epithelial polarity and epithelial barrier by alix-mediated assembly of the actomyosin-tight junction polarity complex, Invitrogen OCLN antibody (Life Technologies, 331588) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig s8). Nat Commun (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 2
In order to analyze how to cease the inflammatory effects of HIV-1 infection in vitro by electro-magnetic nano-particle bound beclin1 siRNA that crosses the blood-brain barrier, Invitrogen OCLN antibody (Thermo Scientific, 331588) was used in immunocytochemistry on human samples (fig 2). J Neuroimmune Pharmacol (2017) ncbi
domestic rabbit monoclonal (6HCLC)
  • western blot; mouse; 1:1000; fig 3
In order to study attenuation of oxazolone-induced colitis in mice through suppression of inflammataion and epithelial barrier disruption via modified pulsatilla decoction, Invitrogen OCLN antibody (Invitrogen, 710192) was used in western blot on mouse samples at 1:1000 (fig 3). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; fig 4
In order to study the intestinal barrier function using Arhgap17-deficient mice, Invitrogen OCLN antibody (Life Technologies, 711500) was used in immunohistochemistry on mouse samples (fig 4). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig 3
  • immunohistochemistry - paraffin section; human; fig 3
In order to characterize and identify a novel tissue barrier in tendon blood vessels, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on mouse samples (fig 3) and in immunohistochemistry - paraffin section on human samples (fig 3). Eur Cell Mater (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; rat; 2.5 ug/ml; fig 5
  • immunoprecipitation; rat; 3 ug/ml; fig 5
  • western blot; rat; 0.5 ug/ml; fig 5
In order to study the increase of nectin-3 in the cell junctions of the uterine epithelium at implantation, Invitrogen OCLN antibody (Life Technologies Australia Pty, 33-1500) was used in immunohistochemistry - frozen section on rat samples at 2.5 ug/ml (fig 5), in immunoprecipitation on rat samples at 3 ug/ml (fig 5) and in western blot on rat samples at 0.5 ug/ml (fig 5). Reprod Sci (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; rat; 1:100; fig 4
  • western blot; rat; 1:500; fig 2
In order to analyze hyperoxia-induced pulmonary epithelial barrier breakdown and how caveolin-1 regulates the expression of tight junction proteins, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in immunocytochemistry on rat samples at 1:100 (fig 4) and in western blot on rat samples at 1:500 (fig 2). Respir Res (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 2
In order to elucidate regulation of E-cadherin and CD24 by determination of cell fate transition and impeding tumor initiation and progression in breast cancer via HOXA5, Invitrogen OCLN antibody (Thermo Fisher Scientific, 71-1500) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 2). Oncogene (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; fig s6
In order to identify transcription factors involved in pancreatic ductal adenocarcinoma pathogenesis, Invitrogen OCLN antibody (Life Technologies, 711500) was used in immunohistochemistry on mouse samples (fig s6). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; mouse; fig 1
In order to characterize induction of lactation-specific tight junctions concurrent with beta-casein expression in mammary epithelial cells due to prolactin and glucocorticoid signaling, Invitrogen OCLN antibody (Life Technologies, 33-1500) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Biochim Biophys Acta (2016) ncbi
domestic rabbit polyclonal
  • western blot; pigs ; 1:1000; fig 3
  • western blot; human; 1:1000; fig 3
In order to determine expression of epithelial as well as mesenchymal cell adhesion molecules in 293 cells, Invitrogen OCLN antibody (Zymed, 71-1500) was used in western blot on pigs samples at 1:1000 (fig 3) and in western blot on human samples at 1:1000 (fig 3). Int J Mol Med (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; mouse; 1:300; fig 4
  • western blot; mouse; 1:3000; fig 4
In order to study recruitment of PDZD11 to adherens junctions to stabilize nectins via PLEKHA7, Invitrogen OCLN antibody (Zymed Laboratories, 33-1500) was used in immunocytochemistry on mouse samples at 1:300 (fig 4) and in western blot on mouse samples at 1:3000 (fig 4). J Biol Chem (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; pigs ; 1:100; fig 3
In order to characterize cell junction assembly in early porcine embryo development by ADAM10, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on pigs samples at 1:100 (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 4
In order to utilize a unique in vitro platform to learn about development of Toll-like receptor 4-targeted therapeutic options and the study of SN38-induced mucosal damage, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples (fig 4). Exp Biol Med (Maywood) (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; fig 2
In order to study the reduction of paracellular permeability of rat brain endothelial cells exposed to ischemia-like conditions by adropin, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in western blot on rat samples at 1:1000 (fig 2). Peptides (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:250; fig 3
In order to determine regulation of ectoplasmic specialization dynamics via its effects on actin microfilaments in the testes of male rats by planar cell polarity (PCP) protein Vangl2, Invitrogen OCLN antibody (Invitrogen, 711500) was used in western blot on rat samples at 1:250 (fig 3). Endocrinology (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig 2
In order to analyze tight junction protein expression in mal de Meleda by use of immunohistological studies, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on human samples (fig 2). Ultrastruct Pathol (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 2
In order to utilize human alveolar epithelial cells expressing tight junctions as an air-blood barrier model, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples at 1:200 (fig 2). ALTEX (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig s2
In order to utilize a novel mouse model with retinal detachment caused by a disruption of protein kinase C, theta, to study retinal pigment epithelium atrophy 1 (rpea1), Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on mouse samples (fig s2). Invest Ophthalmol Vis Sci (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; fig 8
In order to study enhancing mucosal inflammation by chronic ethanol feeding that promotes azoxymethane and dextran sulfate sodium-induced colonic tumorigenesis, Invitrogen OCLN antibody (Invitrogen, 331500) was used in immunohistochemistry - frozen section on mouse samples (fig 8). BMC Cancer (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 1:1000; fig 1
In order to study a reconstituted choroid plexus epithelium to show T-lymphocytes traffic into the brain across the blood-CSF barrier, Invitrogen OCLN antibody (Life Technologies, 71-1500) was used in immunocytochemistry on mouse samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; domestic sheep; 1:50; fig 4
In order to determine if monitoring of fetal intestinal inflammation by heart rate variability analysis can signal incipient necrotizing enterocolitis of the neonate, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry - paraffin section on domestic sheep samples at 1:50 (fig 4). Pediatr Crit Care Med (2016) ncbi
mouse monoclonal (OC-3F10)
  • western blot knockout validation; human; fig 1
In order to determine the contribution of occludin to hepatitis C virus infection, Invitrogen OCLN antibody (Thermo Fisher, noca) was used in western blot knockout validation on human samples (fig 1). Biol Pharm Bull (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 6
  • immunohistochemistry; mouse; 1:200; fig 5
In order to study disruption of retinal pigment epithelial structure and function with features of age-related macular degeneration caused by hyperhomocysteinemia, Invitrogen OCLN antibody (Invitrogen, 331500) was used in immunocytochemistry on human samples at 1:200 (fig 6) and in immunohistochemistry on mouse samples at 1:200 (fig 5). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6
In order to study disruption of retinal pigment epithelial structure and function with features of age-related macular degeneration caused by hyperhomocysteinemia, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit polyclonal
In order to evaluate the blood-brain barrier in adult rats and morphological changes due to restraint stress-induction, Invitrogen OCLN antibody (Thermo Fisher Scientific, 71-1500) was used . Front Mol Neurosci (2015) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 3
  • western blot; dogs; fig 3
In order to study the effects of glycogen storage in cells from the seminiferous tubules, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in western blot on mouse samples (fig 3) and in western blot on dogs samples (fig 3). J Cell Physiol (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig 3
In order to study the impact of Faecalibacterium prausnitzii in a mouse model of irritable bowel syndrome, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on mouse samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:50; fig 3
In order to assess purinergic receptor P2RY12-dependent microglial closure to blood-brain barrier injuries, Invitrogen OCLN antibody (Life Technologies, 33-1500) was used in immunohistochemistry on mouse samples at 1:50 (fig 3). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit recombinant (6H10L9)
  • western blot; human; 1:3000; loading ...; fig 8
In order to assess the effects of actinidin on intestinal epithelium tight junctions, Invitrogen OCLN antibody (Thermo Scientific, ABfinity (No catalogue number)) was used in western blot on human samples at 1:3000 (fig 8). Biochim Biophys Acta (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; rat; 1:50; tbl 2
In order to test if overexpression of Connexin 43 in adjudin-treated rats reseals the disrupted blood-testis barrier and reinitiates spermatogenesis, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in immunohistochemistry - frozen section on rat samples at 1:50 (tbl 2). FASEB J (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 4c
  • western blot; mouse; 1:2000; loading ...; fig 4b
In order to test if vitamin D signaling ameliorates lipopolysaccharide-induced acute lung injury by altering barrier integrity, Invitrogen OCLN antibody (Cell Signaling, 331500) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 4c) and in western blot on mouse samples at 1:2000 (fig 4b). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; dogs; 1:600; fig 1
In order to investigate how tight junctions regulate allergen penetration in atopic dermatitis, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in immunohistochemistry - paraffin section on dogs samples at 1:600 (fig 1). Vet Dermatol (2016) ncbi
domestic rabbit polyclonal
  • western blot; bovine; fig 3
In order to study two bovine mammary epithelial cell lines in 2D and 3D models for functional and phenotypic characterization, Invitrogen OCLN antibody (Zymed, 71-1500) was used in western blot on bovine samples (fig 3). Am J Physiol Cell Physiol (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
In order to establish and characterize long-term, stable 3D organoid cultures derived from human fallopian tubes, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Nat Commun (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1
In order to assess the capacity of primary synovial fibroblasts to support hepatitis C virus propagation, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; fig s2
  • ELISA; human; 1:50; fig s2
  • western blot; human; fig s2
In order to analyze control of HIV transcription in brain pericytes by occludin via regulation of SIRT-1 activation, Invitrogen OCLN antibody (Thermo Scientific, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig s2), in ELISA on human samples at 1:50 (fig s2) and in western blot on human samples (fig s2). FASEB J (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; rat; 2.5 ug/ml; fig 4
  • western blot; rat; 1:125; fig 3
In order to study sertoli cell tight junction function in vitro and the role of Claudin-11 and occludin as major contributors, Invitrogen OCLN antibody (Zymed, 71-1500) was used in immunocytochemistry on rat samples at 2.5 ug/ml (fig 4) and in western blot on rat samples at 1:125 (fig 3). Asian J Androl (2016) ncbi
domestic rabbit polyclonal
In order to characterize axolotl spinal cord regeneration and how induction of neural stem cell expansion occurs by planar cell polarity-mediation, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used . elife (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 2
In order to describe methods to differentiate and characterize hPSC-derived brain microvascular endothelial cells, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples at 1:200 (fig 2). Methods (2016) ncbi
domestic rabbit polyclonal
In order to study the transmigration of neuroblastoma cells across the blood-cerebrospinal fluid barrier in vitro, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used . Cancer Cell Int (2015) ncbi
domestic rabbit polyclonal
In order to create and characterize a model for kidney disease using CRISPR-mutants, Invitrogen OCLN antibody (Thermo Fisher Scientific, 71-1500) was used . Nat Commun (2015) ncbi
domestic rabbit polyclonal
In order to examine the effect of advanced glycation end products on the retina, Invitrogen OCLN antibody (Invitrogen Life Technologies, 711500) was used . Mol Med Rep (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1c
In order to elucidate the contribution of SPRY2 to colon cancer, Invitrogen OCLN antibody (Life Technologies, 71-1500) was used in western blot on human samples (fig 1c). Oncogene (2016) ncbi
domestic rabbit polyclonal
In order to characterize two clones from triple negative breast MDA-MB-231 cancer cells, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used . Exp Cell Res (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1,2,3
In order to research pancreatic epithelial cells and a possible sensor system through the hippo pathway co-localizing with occludin, Invitrogen OCLN antibody (Invitrogen, 33-C1500) was used in western blot on human samples (fig 1,2,3). Tissue Barriers (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 5 ug/ml
In order to assess epithelial tight junctions, cytokine production, and matrix metalloproteinase profiles in patients undergoing chemotherapy, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry on human samples at 5 ug/ml. Support Care Cancer (2016) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 4
In order to study the use of microfluidics in temporal monitoring of differentiated human airway epithelial cells, Invitrogen OCLN antibody (Life Technologies, OC-3F10) was used in immunocytochemistry on human samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; fig 2b
In order to propose that IL-17-producing gammadelta T cells help to maintain and protect the intestinal mucosa, Invitrogen OCLN antibody (Life Technologies, OC-3F10) was used in immunohistochemistry - frozen section on mouse samples (fig 2b). Immunity (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 2b
In order to study the contribution of neutrophil peptides 1 to HIV transmission, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples at 1:200 (fig 2b). Viral Immunol (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:100
  • western blot; mouse; 1:250
In order to study the effects of Abeta on the functionality of the blood-CSF barrier, Invitrogen OCLN antibody (Life Technologies, 33-1500) was used in immunohistochemistry on mouse samples at 1:100 and in western blot on mouse samples at 1:250. J Neurosci (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:50
  • western blot; human; 1:200
In order to elucidate the effects and mechanism of miR-18a on the permeability of the blood-tumor barrier, Invitrogen OCLN antibody (Life Technologies, 33-1500) was used in immunocytochemistry on human samples at 1:50 and in western blot on human samples at 1:200. J Neurosci Res (2015) ncbi
domestic rabbit polyclonal
  • western blot; dogs
In order to examine the role of occludin in H2O2-mediated renal epithelial cell monolayer permeability, Invitrogen OCLN antibody (Life Technologies, 404700) was used in western blot on dogs samples . J Cell Biochem (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; dogs
In order to examine the role of occludin in H2O2-mediated renal epithelial cell monolayer permeability, Invitrogen OCLN antibody (Life Technologies, 71-1500) was used in immunocytochemistry on dogs samples . J Cell Biochem (2016) ncbi
domestic rabbit polyclonal
  • western blot; chicken; 1:1000
In order to test if rapamycin-sensitive target of rapamycin complex 1 pathway is involved in intestinal barrier integrity, Invitrogen OCLN antibody (Beyotime, 71-1500) was used in western blot on chicken samples at 1:1000. J Anim Physiol Anim Nutr (Berl) (2016) ncbi
domestic rabbit polyclonal
In order to test if 2,3,5,6-tetramethylpyrazine protects the blood brain barries integrity in ischemia/reperfusion injury, Invitrogen OCLN antibody (Invitrogen Life Technologies, 71-1500) was used . Exp Ther Med (2015) ncbi
domestic rabbit polyclonal
In order to examine what proteins are produced when carbohydrate-fed healthy humans receive enteral delivery of proteins, Invitrogen OCLN antibody (Life Technologies, 71-1500) was used . Am J Clin Nutr (2015) ncbi
domestic rabbit polyclonal
In order to study modulation of the composition of the gut microbiota by ganoderma lucidum that reduces obesity in mice, Invitrogen OCLN antibody (Invitrogen, 71-1,500) was used . Nat Commun (2015) ncbi
domestic rabbit polyclonal
In order to study the choroid plexus in the fetus, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used . Reprod Toxicol (2015) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - free floating section; mouse; 1:100
In order to assess the vascular permeability of blood-derived molecules and the expression of tight-junction proteins in sensory circumventricular organs, Invitrogen OCLN antibody (Invitrogen, 42?C2400) was used in immunohistochemistry - free floating section on mouse samples at 1:100. Cell Tissue Res (2016) ncbi
domestic rabbit polyclonal
In order to study the role of plastin 3 in ectoplasmic specialization dynamics during spermatogenesis in the rat testis, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used . FASEB J (2015) ncbi
domestic rabbit polyclonal
In order to determine the role of the HGF/c-Met pathway in regulating oval cell migratory and invasive properties, Invitrogen OCLN antibody (Invitrogen, 711500) was used . Biochim Biophys Acta (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:100; fig 3b
In order to compare the effects of two excipients applied to emerged reconstructed human epidermis, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunohistochemistry on human samples at 1:100 (fig 3b). Exp Dermatol (2015) ncbi
domestic rabbit polyclonal
In order to determine effects of low-dose-rate chronic radiation on male fertility, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used . Radiat Prot Dosimetry (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:500; loading ...; fig 3c
  • western blot; rat; 1:500; loading ...; fig 2a
In order to propose that claudin-4 is required for mAChR-modulated paracellular permeability of epithelial cells and investigate the mechanism, Invitrogen OCLN antibody (Life Technologies, 331500) was used in immunocytochemistry on rat samples at 1:500 (fig 3c) and in western blot on rat samples at 1:500 (fig 2a). J Cell Sci (2015) ncbi
domestic rabbit polyclonal
In order to investigate the role of claudin-1/claudin-5 in epithelial/endothelial barriers, Invitrogen OCLN antibody (Life Technologies, 71-1500) was used . Biomaterials (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 2.5 ug/ml
In order to investigate the role of claudin-1/claudin-5 in epithelial/endothelial barriers, Invitrogen OCLN antibody (Life Technologies, 33-1500) was used in immunocytochemistry on human samples at 2.5 ug/ml. Biomaterials (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse
In order to investigate the deficiency of intestine and microbiome in an amyotrophic lateral sclerosis mouse model, Invitrogen OCLN antibody (Zymed, 33-1500) was used in western blot on mouse samples . Physiol Rep (2015) ncbi
domestic rabbit polyclonal
In order to discuss the contribution of epithelial barrier dysfunction to mucosal diseases, including asthma, chronic rhinosinusitis, and eosinophilic esophagitis, Invitrogen OCLN antibody (Life Technologies, 71-1500) was used . J Allergy Clin Immunol (2015) ncbi
domestic rabbit recombinant (6H10L9)
  • western blot; human
Invitrogen OCLN antibody (Thermo Scientific, 6H10L9) was used in western blot on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rhesus macaque; fig s1b
In order to identify cellular determinants of interspecies hepatitis C virus transmission and establish an immunocompetent model system, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in western blot on rhesus macaque samples (fig s1b). Hepatology (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 5
In order to study the impairment of human brain endothelial barrier integrity via integrin alpha-4 transduced outside-in signaling due to soluble VCAM-1, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples (fig 5). Acta Neuropathol (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; fig 6
In order to elucidate the contributions of cell-cell adhesion proteins to intercellular force and epithelial tissue dynamics, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry on human samples (fig 6). Nat Cell Biol (2015) ncbi
domestic rabbit polyclonal
In order to investigate the effect of prostacyclin on pericyte loss and demyelination induced by lysophosphatidylcholine in the central nervous system, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used . J Biol Chem (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dogs; fig 6
  • western blot; dogs; fig 3
In order to identify the members of the tight junction proteome, Invitrogen OCLN antibody (Life Technologies, 33-1500) was used in immunocytochemistry on dogs samples (fig 6) and in western blot on dogs samples (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human
Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunohistochemistry on human samples . PLoS ONE (2015) ncbi
domestic rabbit polyclonal
In order to determine the effect of 17beta-estradiol on blood-spinal cord barrier breakdown, hemorrhage, and subsequent inflammation after spinal cord injury, Invitrogen OCLN antibody (Invitrogen, 40-4700) was used . Endocrinology (2015) ncbi
domestic rabbit polyclonal
In order to generate a new line of conditionally immortalized human brain microvascular endothelial cells to study blood brain barrier function, Invitrogen OCLN antibody (Zymed Laboratories, 71-1500) was used . Fluids Barriers CNS (2015) ncbi
domestic rabbit polyclonal
In order to study the role of astroglial cx43 in immune quiescence of the brain, Invitrogen OCLN antibody (Life Technologies, 71-1500) was used . J Neurosci (2015) ncbi
domestic rabbit polyclonal
In order to investigate the role of LSR/angulin-1 in blood-brain barrier formation, Invitrogen OCLN antibody (Invitrogen, 40-4700) was used . J Cell Biol (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse
In order to investigate the role of LSR/angulin-1 in blood-brain barrier formation, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry - frozen section on mouse samples . J Cell Biol (2015) ncbi
domestic rabbit polyclonal
In order to study the role of Musashi-1 in blood-testis barrier structure during spermatogenesis, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used . Mol Biol Cell (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human
In order to test if foreskin tissue samples from asymptomatic HSV-2 seropositive men had signs of inflammation at the molecular level, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunohistochemistry - frozen section on human samples . BMJ Open (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 6
In order to study human breast cancer cell lines and how Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration, Invitrogen OCLN antibody (Invitrogen, OC-F10) was used in western blot on human samples (fig 6). Oncotarget (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:50
In order to investigate the role of opioid receptor delta in skin differentiation and barrier function repair, Invitrogen OCLN antibody (Life technologies, 33-1500) was used in immunohistochemistry on human samples at 1:50. Int J Cosmet Sci (2015) ncbi
domestic rabbit polyclonal
In order to assess changes to the blood-brain barriers and regional cerebral blood flow in a neonatal model of hypoxic-ischemic encephalopathy, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used . J Cereb Blood Flow Metab (2015) ncbi
domestic rabbit polyclonal
In order to examine the role of the mammalian acid sphingomyelinase/ceramide system in the development of lung edema caused by S. aureus, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used . J Mol Med (Berl) (2015) ncbi
domestic rabbit polyclonal
In order to test if azithromycin attenuates cigarette smoke extract-induced A549 cell oxidative stress injury, Invitrogen OCLN antibody (Invitrogen Life Technologies, 71-1500) was used . Mol Med Rep (2015) ncbi
domestic rabbit polyclonal
In order to report the signaling mechanisms by which PKC-zeta activation affects EMAP-II-induced BTB hyperpermeability, Invitrogen OCLN antibody (Invitrogen, 71-C1500) was used . Exp Cell Res (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; guinea pig
In order to characterize transcription factor AP-2gamma in early embryonic development of porcine parthenotes, Invitrogen OCLN antibody (ZYMED, 33-1500) was used in immunohistochemistry on guinea pig samples . Reprod Fertil Dev (2015) ncbi
domestic rabbit polyclonal
In order to assess the effects of different cell culturing conditions on the Calu-3 epithelial cell model, Invitrogen OCLN antibody (Zymed-Life Technologies, 71-1500) was used . Eur J Pharm Sci (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100
  • western blot; human
Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:100 and in western blot on human samples . Infect Immun (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:1000
In order to study how DLC2 regulates cell junction maintenance and planar spindle positioning, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples at 1:1000. Nat Commun (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human
  • western blot; human
In order to investigate the effect of homoharringtonine on intestinal epithelial permeability and its mechanism, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples and in western blot on human samples . Eur J Pharm Biopharm (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; mouse; 1:500; fig 3
In order to study the contribution of ZO-1, -2, and -3 on collecting duct cell proliferation, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunocytochemistry on mouse samples at 1:500 (fig 3). Cell Cycle (2014) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 5 ug/ml
  • western blot; mouse; 2 ug/ml
In order to assess the neuroprotective features of acetyl-L-carnitine in methamphetamine-induced damage, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used in immunocytochemistry on mouse samples at 5 ug/ml and in western blot on mouse samples at 2 ug/ml. Mol Neurobiol (2016) ncbi
domestic rabbit polyclonal
In order to study the role of EB1 in tubulin and actin cytoskeletal networks at the sertoli cell blood-testis barrier, Invitrogen OCLN antibody (Invitrogen, 71-1500) was used . Endocrinology (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:1000; loading ...; fig 6b
In order to develop an efficient system to culture hepatitis C virus, Invitrogen OCLN antibody (Life Technologies, OC-3F10) was used in western blot on human samples at 1:1000 (fig 6b). Jpn J Infect Dis (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; Xenopus laevis; fig 3
In order to investigate matrix metalloproteinase expression in the Xenopus laevis corneal epithelium, Invitrogen OCLN antibody (Invitrogen, 331500) was used in immunohistochemistry - frozen section on Xenopus laevis samples (fig 3). PLoS ONE (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:300; fig 4
  • western blot; mouse; 1:1000
In order to study the blood-brain barrier function in germ free mice, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry on mouse samples at 1:300 (fig 4) and in western blot on mouse samples at 1:1000. Sci Transl Med (2014) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:1000; fig 3
In order to demonstrate that emodin attenuates LPS- and hypoxia/reoxygenation-induced intestinal epithelial barrier dysfunction by inhibiting the HIF-1alpha and NF-kappaB signaling pathways, which regulate tight junctions, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in western blot on human samples at 1:1000 (fig 3). Int J Mol Med (2014) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human
In order to study tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in western blot on human samples . Surg Obes Relat Dis (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; domestic sheep; 1:500
In order to study the effect of a high-concentrate diet on colonic epithelial barrier and cell apoptosis in lactating goats, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in western blot on domestic sheep samples at 1:500. BMC Vet Res (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
In order to research aggravation of murine caerulein-induced acute pancreatitis and the favoring of acinar keratin granule formation due to epiplakin deficiency, Invitrogen OCLN antibody (Life Technologies, OC-3F10) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). PLoS ONE (2014) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human
Invitrogen OCLN antibody (Zymed laboratories, OC-3F10) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:400
In order to examine the localization of epithelial junctions in relation to paracellular permeability and intestinal adhesion, Invitrogen OCLN antibody (Life Technologies, 33-1500) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:400. Exp Toxicol Pathol (2014) ncbi
domestic rabbit polyclonal
In order to study using RPMI 2650 cells to create an in vitro model of the nasal mucosa, Invitrogen OCLN antibody (Zymed-Life Technologies, 71-1500) was used . Pharm Res (2015) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:1000; loading ...; fig 1c
In order to examine the roles of scavenger receptor class B type I, CD81, claudin 1, and occludin in Hepatitis C virus infection, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples at 1:1000 (fig 1c). J Virol (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 3
In order to assess the role of Toll-like receptor 2 in maintaining the integrity of the airway epithelial barrier, Invitrogen OCLN antibody (InvitrogenAG, 33-1500) was used in immunocytochemistry on human samples (fig 3). Tissue Barriers (2014) ncbi
domestic rabbit polyclonal
In order to investigate the localization of POF1B in desmosomes and its role in human intestinal and keratinocyte cell lines, Invitrogen OCLN antibody (Zymed Laboratories, 71-1500) was used . J Invest Dermatol (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:200
In order to evaluate the cystathionine-beta-synthase heterozygous mice as a model of mild to moderate hyperhomocysteinemia, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry on mouse samples at 1:200. Am J Pathol (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; 1:250
In order to study the role of tight junction alterations in cavernous malformations, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry - frozen section on human samples at 1:250. J Neurosurg (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig 5b
In order to study the role of TH9 cells in ulcerative colitis, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 5b). Nat Immunol (2014) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; 1:1000
In order to characterize transmural intestinal wall permeability in severe ischemia after enteral protease inhibition, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in western blot on rat samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:200
  • western blot; rat; 1:200
In order to study hepatocyte polarity and various claudins that are expressed in tight junctions of cell lines, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on rat samples at 1:200 and in western blot on rat samples at 1:200. Tissue Barriers (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human
In order to investigate the role of lipolysis stimulated lipoprotein receptor in aggressive breast cancer behavior, Invitrogen OCLN antibody (Zymed, 33-1500) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; loading ...; fig s5
In order to identify a cell line that supports the entire life cycle of hepatitis B and hepatitis C viruses, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples (fig s5). Proc Natl Acad Sci U S A (2014) ncbi
domestic rabbit polyclonal
In order to determine the quantity, distribution and function of tight junction proteins in patients undergoing dialysis treatments, Invitrogen OCLN antibody (Zymed, 71-1500) was used . Perit Dial Int (2015) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; guinea pig; 1:250
  • western blot; guinea pig; 1:500
In order to study the effect of retinoic acid on the tight junctions of the retinal pigment epithelium-choroid complex of guinea pigs, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry on guinea pig samples at 1:250 and in western blot on guinea pig samples at 1:500. Int J Mol Med (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; 1:150
  • western blot; mouse; 1:200
In order to examine how glutamate modulates intestinal epithelial cell growth and epithelial barrier function during total parenteral nutrition, Invitrogen OCLN antibody (Life Technologies, 331500) was used in immunohistochemistry - frozen section on mouse samples at 1:150 and in western blot on mouse samples at 1:200. FASEB J (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100
  • western blot; human
In order to study the effect of Shigella species and its vaccine candidates on small intestinal barrier function and immune response, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples at 1:100 and in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100
In order to study cord blood as a source of circulating endothelial progenitor cells that can be directed towards specialized endothelial phenotypes, Invitrogen OCLN antibody (Invitrogen, 33?C1500) was used in immunocytochemistry on human samples at 1:100. PLoS ONE (2014) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; 1:1000
In order to investigate the effect of intestinal contents on hemorrhagic shock, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in western blot on rat samples at 1:1000. Physiol Rep (2013) ncbi
domestic rabbit polyclonal
In order to study the effect of activity-based anorexia on intestinal barrier function in mice, Invitrogen OCLN antibody (Zymed Laboratories, 71-1500) was used . Clin Nutr (2014) ncbi
mouse monoclonal (OC-3F10)
  • western blot; pigs ; 1:500
In order to investigate the effect of intraluminal acid on esophageal nodose C fibers after mast cell activation, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in western blot on pigs samples at 1:500. Am J Physiol Gastrointest Liver Physiol (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dogs
  • western blot; dogs
In order to investigate the effect of ouabain on endocytosis and degradation of tight junction proteins, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on dogs samples and in western blot on dogs samples . Exp Cell Res (2014) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; mouse; 1:100; fig 2
In order to study the role of Cldn6 in epithelial differentiation, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunocytochemistry on mouse samples at 1:100 (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 2
In order to investigate the expression of the tight junction proteins occludin, claudin-1 and ZO-2 in the epidermis of female mice, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2). Exp Cell Res (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 3
In order to study collective cell movement, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples (fig 3). Biol Open (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; fig 2
  • immunohistochemistry; human; 1:100; fig 1
In order to report that tight junctions are physiological regulated by sex hormones during the menstrual cycle, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig 2) and in immunohistochemistry on human samples at 1:100 (fig 1). Cell Tissue Res (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; mouse; fig 5
In order to optimize a scaffold needed to generate an artificial salivary gland, Invitrogen OCLN antibody (Life Technologies, 33-1500) was used in immunocytochemistry on mouse samples (fig 5). Biomaterials (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat
In order to evaluate protocols for the isolation and culture of endothelial cells from rate brain and spinal cord, Invitrogen OCLN antibody (Life Technologies, 33-1500) was used in immunocytochemistry on rat samples . BMC Neurosci (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 2.5 ug/ml; fig 5
  • western blot; human; 2 ug/ml; fig 5
In order to study the mechanisms underlying cell-cell contact-mediated HCV transfer and infection, Invitrogen OCLN antibody (Zymed/Invitrogen, 33-1500) was used in immunocytochemistry on human samples at 2.5 ug/ml (fig 5) and in western blot on human samples at 2 ug/ml (fig 5). J Virol (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to elucidate the anti-viral effect of amiodarone on HCV life cycle, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 2). Clin Sci (Lond) (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; domestic sheep; 1:5000; fig 2
In order to examine the photoperiodically different concentration of polychlorinated biphenyls in the cerebrospinal fluid in sheep, Invitrogen OCLN antibody (Invitrogen, OC-3 F10) was used in western blot on domestic sheep samples at 1:5000 (fig 2). Neurotoxicol Teratol (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 4
In order to investigate the role of occludin in hepatitis C virus cell entry, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in western blot on human samples (fig 4). PLoS Pathog (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human
In order to demonstrate the effect of HIV-1 Tat C on miRNA-101 expression in human brain microvascular endothelial cells, Invitrogen OCLN antibody (Invitrogen, 33-1520) was used in western blot on human samples . J Neurosci (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 8a
In order to assess in vitro the effects of several S. Typhi strains and the licensed Ty21a typhoid vaccine on intestinal barrier function and immune response, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in western blot on human samples (fig 8a). Front Immunol (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 2
  • western blot; human; 1:3000; fig 2
In order to examine the contribution of various tight junction proteins in keratinocytes, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples at 1:3000 (fig 2). J Invest Dermatol (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; loading ...; fig s2
In order to study regulatory mechanisms that modulate Snail and claudin-1 via a PKCalpha during the epithelial-mesenchymal transition of pancreatic cancer cells, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig s2). Carcinogenesis (2013) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1, 2
In order to study the roles of MAPK-related kinase and MKNK-1 in HCV replication and cellular entry, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in western blot on human samples (fig 1, 2). J Virol (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; fig 3
In order to examine innate responses to Entamoeba histolytica in wild-type and MUC-2-deficient mice, Invitrogen OCLN antibody (Invitrogen, 331500) was used in immunohistochemistry - frozen section on mouse samples (fig 3). Am J Pathol (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:100; fig 4
In order to elucidate role of bile acids in fat-induced barrier dysfunction, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry on mouse samples at 1:100 (fig 4). Am J Physiol Gastrointest Liver Physiol (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 1
In order to investigate the assembly and disassembly of tricellular in tight junctions by altering the calcium concentration, Invitrogen OCLN antibody (Zymed Laboratories, OC-3F10) was used in immunocytochemistry on human samples (fig 1). Cell Tissue Res (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:250; fig 7
  • western blot; human; 1:2000; fig 7
In order to study permeability and tight junctions in endothelial cells derived from human cord blood, Invitrogen OCLN antibody (Invitrogen, clone OC-3F10) was used in immunocytochemistry on human samples at 1:250 (fig 7) and in western blot on human samples at 1:2000 (fig 7). Am J Physiol Heart Circ Physiol (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 1
In order to develop a solid model of polarized epithelium for human pancreatic ducts to study ion transport, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples (fig 1). Pancreas (2013) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 5
In order to characterize salivary gland epithelial cells cultured on poly(lactic-co-glycolic acid) nanofiber scaffolds, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunocytochemistry on human samples (fig 5). Biomaterials (2012) ncbi
mouse monoclonal (OC-3F10)
In order to evaluate the isolation and culture of adult salivary gland-derived stem/progenitor cells, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used . J Tissue Eng Regen Med (2014) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to test if drugs used in highly active antiretroviral therapy increase susceptibility to HCV infection, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 2). Antiviral Res (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; 1:500; fig 2
In order to assess the role of neuroinflammation in mediating the effects of chronic stress exposure and/or methamphetamine on blood brain barrier structure and function, Invitrogen OCLN antibody (Invitrogen, 331500) was used in western blot on rat samples at 1:500 (fig 2). J Neuroimmune Pharmacol (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; 1:250; fig 3
In order to study the role of COX-2 in the upregulation of CNS laminin in a murine model of ischemic injury, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunohistochemistry on mouse samples at 1:250 (fig 3). J Neuroinflammation (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human
In order to report the consequences of modulating PP2A phosphatase activity in human mammary epithelial cells, Invitrogen OCLN antibody (Zymed Laboratories, OC-3F10) was used in western blot on human samples . PLoS Genet (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:250; fig 4a
In order to study the role of mucins in apical endocytic trafficking using RNAi-mediated knockdown of core 1 beta-1,3-galactosyltransferase in human corneal keratinocytes, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in western blot on human samples at 1:250 (fig 4a). PLoS ONE (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; rat; 1:50; fig 4a
In order to assess the effects of opioids on tight junction proteins, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunohistochemistry - paraffin section on rat samples at 1:50 (fig 4a). Anesthesiology (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1
In order to assess the effect of 9-cis-retinoic acid and all-trans retinoic acid on the formation and degradation of gap junctions and junctional communication in cancer cells, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 1). PLoS ONE (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; rat; fig 6
In order to study the junctional complexes of liver sinusoidal endothelial cells, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry on rat samples (fig 6). PLoS ONE (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; domestic rabbit; 1:200; fig 2
In order to test if simvastatin blocks disruption of the blood brain barrier induced by cholesterol in vivo and in vitro, Invitrogen OCLN antibody (Zymed, clone OC-3F10) was used in immunohistochemistry - frozen section on domestic rabbit samples at 1:200 (fig 2). Int J Alzheimers Dis (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 3
In order to study non-small cell lung carcinoma cell lines treated with cisplatin, doxorubicin, and gemcitabine, Invitrogen OCLN antibody (Invitrogen, clone OC-3F10) was used in western blot on human samples (fig 3). Cancer Lett (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; domestic rabbit; 1:200; fig 4
In order to characterize infant rabbits infected with Vibrio parahaemolyticus, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry - paraffin section on domestic rabbit samples at 1:200 (fig 4). PLoS Pathog (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dogs; fig 1
  • western blot; dogs; fig 2, 4
In order to examine the effect of treating epithelial cells with an inhibitor of the lipid kinase PIKfyve, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on dogs samples (fig 1) and in western blot on dogs samples (fig 2, 4). PLoS ONE (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:100; fig 1
In order to examine the expression of tricellulin in normal human pancreas, and in primary exocrine and endocrine pancreatic tumors, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunohistochemistry on human samples at 1:100 (fig 1). Histopathology (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 2
In order to describe an in vitro model of the gastric barrier using moderately differentiated adenocarcinoma stomach cells, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on human samples (fig 2). Food Funct (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1
In order to assess the changes in claudins function via PKCalpha activation in pancreatic cancer cells, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 1). Cell Tissue Res (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; 2.5 ug/ml; fig 3
In order to establish and characterize a three-dimensional organotypic model of the human airway mucosa, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunohistochemistry - frozen section on human samples at 2.5 ug/ml (fig 3). Am J Physiol Lung Cell Mol Physiol (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to report that Honokiol inhibits hepatitis C virus infection in vitro, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 2). Liver Int (2012) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; rat; 1:200; fig 1
  • western blot; rat; 1:1000; fig 6
In order to determine the effects of ischemia-reperfusion injury on expression and distribution of the tight junction proteins in rat kidney, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunohistochemistry - paraffin section on rat samples at 1:200 (fig 1) and in western blot on rat samples at 1:1000 (fig 6). Histochem Cell Biol (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; fig 6
In order to investigate the contribution of the alpha7 nicotinic acetylcholine receptor to bacterial meningitis, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in western blot on mouse samples (fig 6). PLoS ONE (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; mouse; fig 5
In order to show that adenosine receptor signaling modulates blood brain barrier permeability in vivo, Invitrogen OCLN antibody (Invitrogen, 3F10) was used in immunocytochemistry on mouse samples (fig 5). J Neurosci (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; fig 9
In order to determine the effects of FXYD5 on the paracellular permeability using a mouse kidney collecting duct cell line, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in western blot on mouse samples (fig 9). Am J Physiol Renal Physiol (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to examine the effect of the accessory HIV-1 Nef protein on a human epithelial cell line, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 2). PLoS ONE (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; fig 9a
In order to determine the mechanisms by which Gardia intestinalis induces host intestinal epithelium alterations, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig 9a). Cell Microbiol (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; fig 2
  • western blot; human; 1:1000; fig 1
In order to elucidate the role and regulation of marvelD3 in normal epithelial cells and cancer cells, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig 2) and in western blot on human samples at 1:1000 (fig 1). Exp Cell Res (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:1000; fig 4
  • immunocytochemistry; dogs; 1:25; fig 1
In order to demonstrate that ESCRT proteins are required to maintain polarity in mammalian epithelial cells, Invitrogen OCLN antibody (Zymed, 33-1500) was used in western blot on human samples at 1:1000 (fig 4) and in immunocytochemistry on dogs samples at 1:25 (fig 1). Mol Biol Cell (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 4
In order to investigate neoplastic transformation of telomerase in immortalized human fibroblasts, Invitrogen OCLN antibody (Zymed, 33-1500) was used in western blot on human samples (fig 4). Int J Oncol (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 6
In order to characterize distinct, flat and island-forming Caco-2 cells, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on human samples (fig 6). J Pharm Sci (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to investigate how the differences between human and murine occludin contribute to hepatitis C virus spread, Invitrogen OCLN antibody (Zymed/Invitrogen, clone OC-3F10) was used in western blot on human samples (fig 2). J Virol (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; mouse; fig 3
In order to determine the role of hypoxia-inducible factor-1 in high glucose-induced endothelial permeability of the blood brain barrier, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in western blot on mouse samples (fig 3). Cell Mol Life Sci (2012) ncbi
mouse monoclonal (OC-3F10)
  • western blot; domestic sheep; 1:5000; fig 1
In order to compare the tight junction proteins in the choroid plexus of ewes exposed to short or long days, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in western blot on domestic sheep samples at 1:5000 (fig 1). Brain Res (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to study the role of adhesion mlecules and proteases in the penetration/invasion of ovarian tumor cells into extracellular matrices, Invitrogen OCLN antibody (NeoMarkers, clone OC-3F10) was used in western blot on human samples (fig 2). PLoS ONE (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; pigs ; fig 1
In order to use a guinea pig exchange transfusion model to study the effects of cell-free hemoglobin, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in western blot on pigs samples (fig 1). Am J Pathol (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; mouse; fig 4
  • western blot; mouse; fig 4
In order to study the role of CD44 in tight-junction assembly and barrier function, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunohistochemistry on mouse samples (fig 4) and in western blot on mouse samples (fig 4). J Invest Dermatol (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 2.5 ug/ml; loading ...; fig 5a
  • western blot; human; loading ...; fig 6a
In order to discuss the role of tight junctions to the development of atopic dermatitis, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 2.5 ug/ml (fig 5a) and in western blot on human samples (fig 6a). J Allergy Clin Immunol (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 1
In order to determine the regulation of JAM-A expression in brain endothelial cells and evaluate sJAM-A as a biomarker of blood-brain barrier function, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig 1). PLoS ONE (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig s2
  • western blot; human; fig 2
In order to elucidate the role of PDZK1 in scavenger receptor class B type I-mediate hepatitis C virus entry, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig s2) and in western blot on human samples (fig 2). PLoS Pathog (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; fig 1a
In order to investigate the regulation of the Cx43 assembly by E-cadherin and N-cadherin, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on rat samples (fig 1a). Mol Biol Cell (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:50; tbl 1
  • western blot; rat; 1:250; tbl 1
In order to study protein trafficking in Sertoli cells, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunocytochemistry on rat samples at 1:50 (tbl 1) and in western blot on rat samples at 1:250 (tbl 1). Exp Cell Res (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 2
In order to investigate the regulatory mechanisms of the PAR complex, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig 2). Curr Biol (2010) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1
In order to test if cells originating from the brain or central nervous system are permissive for HCV cell entry, RNA replication, and virus assembly, Invitrogen OCLN antibody (Zymed, clone OC-3F10) was used in western blot on human samples (fig 1). J Viral Hepat (2011) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; loading ...; fig 3a
In order to examine the expression of tight junction proteins in normal human pancreatic duct epithelial cells, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig 3a). Am J Pathol (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dogs; 1:50; fig 2
In order to investigate the role of CRTAM in epithelial cell adhesion, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on dogs samples at 1:50 (fig 2). J Cell Biochem (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100; fig 2
  • western blot; human; 1:1000; fig 2
In order to test if the c-Jun N-terminal kinase pathway regulates tricellulin, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:100 (fig 2) and in western blot on human samples at 1:1000 (fig 2). J Cell Physiol (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; rat; 1:200; fig 5
In order to use rats to test if changes in gut epithelial function and microbiota are diet- or obesity-associated, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry on rat samples at 1:200 (fig 5). Am J Physiol Gastrointest Liver Physiol (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; loading ...; fig 2a
  • western blot; human; loading ...; fig 3a
In order to report that MMP-8 activity contributes to disassembly of cell junction components and cell adhesion during meningococcal infection, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig 2a) and in western blot on human samples (fig 3a). PLoS Pathog (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 2
In order to determine the localization of TGFbeta receptors and ligand secretion in polarizing colonic cells, Invitrogen OCLN antibody (Zymed, 33-1,500) was used in immunocytochemistry on human samples (fig 2). J Cell Physiol (2010) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:500; fig 3
In order to discuss the impact of corticosteroid treatment on hepatitis C virus recurrence after liver transplantation, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples at 1:500 (fig 3). Gastroenterology (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 1
In order to show that the entire hepatitis C virus life cycle is recapitulated in micropatterned cocultures of primary human hepatocytes, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on human samples at 1:200 (fig 1). Proc Natl Acad Sci U S A (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; cat; 1:50; fig 2c
  • immunohistochemistry; human; 1:50; fig 2a
In order to investigate if the expression pattern of tight junction proteins in mice, rabbits, and cats resemble those of humans, Invitrogen OCLN antibody (Invitrogen, 33-1500) was used in immunohistochemistry on cat samples at 1:50 (fig 2c) and in immunohistochemistry on human samples at 1:50 (fig 2a). Biotech Histochem (2011) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1c
In order to investigate the effect of E-cadherin on gap junction formation in cancer cells, Invitrogen OCLN antibody (Zymed Laboratories Inc, OC-3F10) was used in western blot on human samples (fig 1c). J Biol Chem (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:100; fig 2
In order to determine the expression and localization of tricellulin, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunohistochemistry on human samples at 1:100 (fig 2). Med Mol Morphol (2009) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:25; fig 3
  • western blot; human; 1:1000; fig 3
In order to examine the role of Fhit during tumor cell invasion, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:25 (fig 3) and in western blot on human samples at 1:1000 (fig 3). Oncogene (2010) ncbi
mouse monoclonal (OC-3F10)
  • western blot; domestic sheep; 1:5000; fig 3a
In order to measure the expression of tight junction proteins in the cerebral cortex, cerebellum, and spinal cord of fetuses after maternal treatment with dexamethasone, Invitrogen OCLN antibody (Zymed, 33-1500) was used in western blot on domestic sheep samples at 1:5000 (fig 3a). Am J Physiol Heart Circ Physiol (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 5h
  • western blot; human; fig 4a
In order to clarify the role of epithelial-derived thymic stromal lymphopoietin in allergic rhinitis, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig 5h) and in western blot on human samples (fig 4a). Cell Tissue Res (2009) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; 1:50; fig 1
In order to observe the barrier function of cultivated limbal and oral mucosal epithelial sheets, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 1). Invest Ophthalmol Vis Sci (2009) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 5
In order to measure tyrosine-phosphorylated proteins abundance in T cell, B cells, and nonlymphoid cells, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 5). Proteomics (2009) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; rat; 2 ug/ml
  • western blot; rat; 2.5 ug/ml
In order to examine the cellular distributions of tight junction components during early pregnancy and under various hormonal regimens, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunohistochemistry - frozen section on rat samples at 2 ug/ml and in western blot on rat samples at 2.5 ug/ml. Acta Histochem (2010) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; rat; 1:5; fig 4
  • western blot; rat; 1:300; fig 7
In order to test if di(2-ethylhexyl) phthalate alters the expression of testicular gap and tight junction proteins, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunohistochemistry - frozen section on rat samples at 1:5 (fig 4) and in western blot on rat samples at 1:300 (fig 7). Microsc Res Tech (2009) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; 1:1000
In order to test if pre-treatment with nitric oxide before ischemia and reperfusion injury affects cell junction proteins and vascular endothelial growth factor, Invitrogen OCLN antibody (Zymed, 33-1500) was used in western blot on rat samples at 1:1000. J Surg Res (2009) ncbi
mouse monoclonal (OC-3F10)
  • western blot; bovine; fig 3
In order to report a novel mechanism of VEGF-induced occludin phosphorylation and ubiquitination that contributes to tight junction trafficking, Invitrogen OCLN antibody (Zymed, 33-1500) was used in western blot on bovine samples (fig 3). J Biol Chem (2009) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; fig 3
In order to test the effect of hypoxia and reoxygenation on oligomeric assemblies of occludin, Invitrogen OCLN antibody (Zymed, 33-1500) was used in western blot on rat samples (fig 3). J Neurochem (2009) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; 1:100; fig 1
In order to study the expression of adherens junction and tight junction components in human peripheral nerve endoneurium, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 1). J Histochem Cytochem (2009) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; 1:500
In order to assess the effects of dietary glutamine or oral antibiotics on the gut barrier function in a rat model of short bowel syndrome, Invitrogen OCLN antibody (Zymed, 33-1500) was used in western blot on rat samples at 1:500. Am J Physiol Gastrointest Liver Physiol (2009) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:100; tbl 3
In order to study the role of claudin-2 in bile canalicular formation, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on rat samples at 1:100 (tbl 3). Histochem Cell Biol (2009) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:50; loading ...; fig 4
  • western blot; human; loading ...; fig 2a
In order to test if patulin alters the barrier function of intestinal cells, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:50 (fig 4) and in western blot on human samples (fig 2a). Toxicol In Vitro (2009) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to elucidate how the keratin intermediate filament network is involved in the establishment and maintenance of cell polarity, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in western blot on human samples (fig 2). J Cell Biol (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dogs; 1:250; loading ...; fig 4b
In order to develop a canine duodenal epithelial cell culture model to study Neospora caninum infection, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on dogs samples at 1:250 (fig 4b). J Parasitol (2009) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 3b
In order to study tight junction proteins in ECV304 cells, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on human samples (fig 3b). Neurosci Lett (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; fig 6
  • western blot; mouse; 1:1000; fig 6
In order to study the effect of caffeine on the blood brain barrier, Invitrogen OCLN antibody (Zymed, clone OC-3F10) was used in immunohistochemistry - frozen section on mouse samples (fig 6) and in western blot on mouse samples at 1:1000 (fig 6). J Neurochem (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200
In order to use mass spectroscopy to identify proteins that contribute to adhesion of human embryonic stem cells, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples at 1:200. Stem Cells (2008) ncbi
mouse monoclonal (OC-3F10)
  • western blot; rat; fig 6
In order to test the effect of lambda-carrageenan-induced peripheral inflammatory pain on occludin, Invitrogen OCLN antibody (Zymed, 33-1500) was used in western blot on rat samples (fig 6). J Neurochem (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2a
In order to study translocation of HIV across the vaginal pluristratified epithelium, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunohistochemistry - paraffin section on human samples (fig 2a). AIDS (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:100
In order to characterize two cell lines to study the blood-brain barrier, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on rat samples at 1:100. J Pharm Sci (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; domestic rabbit; fig 5
  • western blot; domestic rabbit; fig 4
In order to use rabbits to test if chronic ingestion of caffeine protects against high cholesterol diet-induced disruptions of the blood brain barrier, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunohistochemistry - frozen section on domestic rabbit samples (fig 5) and in western blot on domestic rabbit samples (fig 4). J Neuroinflammation (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1d
In order to study M cells in the epithelial barrier of the human adenoid, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunohistochemistry - frozen section on mouse samples (fig 1d). J Mol Histol (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dogs; fig 5
  • western blot; dogs; fig 3
In order to study the effects of cingulin overexpression, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on dogs samples (fig 5) and in western blot on dogs samples (fig 3). Mol Membr Biol (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; fig 2c
In order to develop and characterize a mesenchymal-epithelial coculture system to identify transcriptional regulators of intestinal epithelial cell differentiation, Invitrogen OCLN antibody (Zymed Laboratories, 33-1500) was used in immunocytochemistry on rat samples (fig 2c). Am J Physiol Gastrointest Liver Physiol (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:100; fig 7A
In order to determine whether transforming growth factor-beta down-regulates claudin-1 expression to induce epithelial to mesenchymal transition, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on rat samples at 1:100 (fig 7A). Liver Int (2008) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:100; fig 1
  • western blot; rat; 1:1000; fig 1
In order to test if trafficking of occludin and claudin-5 is essential for forming the tight junction seal between microvascular endothelial cells, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on rat samples at 1:100 (fig 1) and in western blot on rat samples at 1:1000 (fig 1). J Neurochem (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; loading ...; fig 7c
  • immunocytochemistry; human; loading ...; fig 1d-f
  • western blot; human; loading ...; fig 2b
In order to determine the fate of tight junction proteins in the skin during bacterial colonization and infection, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunohistochemistry - frozen section on human samples (fig 7c), in immunocytochemistry on human samples (fig 1d-f) and in western blot on human samples (fig 2b). J Invest Dermatol (2008) ncbi
domestic rabbit polyclonal
In order to describe the novel junctions between endothelial cells of initial lymphatics, Invitrogen OCLN antibody (Zymed Laboratories, 71-1500) was used . J Exp Med (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 4
In order to elucidate the role of Snail in the epithelial to mesenchymal transition, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 4). Mol Endocrinol (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; fig 5
In order to quantify junctional adhesion molecule-A expression in human corneal endothelium and retinal pigment epithelium and examine the impact of a junctional adhesion molecule-A function-blocking antibody on the permeability of cultured retinal pigment ep, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples (fig 5). Invest Ophthalmol Vis Sci (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:100
In order to report that capsid contributes to astrovirus infection-induced diarrhea, Invitrogen OCLN antibody (Invitrogen, OC-3F10) was used in immunocytochemistry on human samples at 1:100. J Virol (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dogs; 1:250; tbl 1
In order to establish and characterize a primary canine duodenal epithelial cell culture, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on dogs samples at 1:250 (tbl 1). In Vitro Cell Dev Biol Anim (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; rat; 1:100; fig 6
In order to analyze lumbar spinal cord proteins present in naive and experimental autoimmune encephalomyelitis rats, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunohistochemistry - frozen section on rat samples at 1:100 (fig 6). Neuroscience (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 1
  • western blot; human; 1:500; fig 3
In order to examine occludin expression and localization in Caco-2 cells infected with rhesus monkey rotavirus, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:200 (fig 1) and in western blot on human samples at 1:500 (fig 3). J Virol (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dogs; 1:100
In order to ascertain the role of ZO-2 in epithelial cells, Invitrogen OCLN antibody (Zymed Laboratories, 33-1500) was used in immunocytochemistry on dogs samples at 1:100. Exp Cell Res (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 6D
In order to report that the hDlg1-MPP7 complex promotes epithelial cell polarity and tight junction formation, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:200 (fig 6D). Mol Biol Cell (2007) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to show that androgens control the expression level of connexin32 in prostate cancer cells, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 2). Mol Biol Cell (2006) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:50; fig 2
In order to test if the expression of tight junction proteins increases in vessels of germinal matrix and cortex with gestational age, Invitrogen OCLN antibody (Zymed, 33-1,500) was used in immunohistochemistry on human samples at 1:50 (fig 2). Histochem Cell Biol (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; domestic rabbit; 10,000 ug/ml; loading ...; fig 3d
In order to develop and assess artificial cornea materials for in vivo use, Invitrogen OCLN antibody (ZYMED, OC- 3F10) was used in immunohistochemistry - paraffin section on domestic rabbit samples at 10,000 ug/ml (fig 3d). J Biomed Mater Res B Appl Biomater (2007) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dogs
In order to study ouabain-sensitive and -resistant MDCK cells, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on dogs samples . Proc Natl Acad Sci U S A (2006) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; loading ...; fig 4
In order to measure tight junction mRNA and protein levels in patients with edema, venous leg ulcers, and healthy controls, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 4). Int J Mol Med (2006) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; domestic rabbit; 2 ug/ml; fig 8
In order to determine the distribution of claudins-7 and -8 in rabbit Henle's loops and collecting ducts, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunohistochemistry on domestic rabbit samples at 2 ug/ml (fig 8). Nephrol Dial Transplant (2006) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; 1:1000; loading ...; fig 2
In order to elucidate how IFN-gamma alters macromolecular permeability, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples at 1:1000 (fig 2). J Cell Sci (2005) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 2
In order to study tight junctions in CaSki cells treated with ATP or diacylglyceride sn-1,2-dioctanoyl diglyceride, Invitrogen OCLN antibody (Zymed, 33-1500) was used in western blot on human samples (fig 2). Endocrinology (2006) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; pigs ; 1:100
In order to characterize a permanent porcine intestinal epithelial cell line to use as an in vitro infection model, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on pigs samples at 1:100. Histochem Cell Biol (2006) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; loading ...; fig 4d
In order to evaluate a new biocompatible artificial cornea scaffold, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples (fig 4d). J Biomed Mater Res B Appl Biomater (2006) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:200; fig 4c
In order to show that irradiated progeny of enterocytic precursor cells proliferate and differentiate, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:200 (fig 4c). Int J Radiat Biol (2005) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human; 1:250; loading ...; fig 4b
  • western blot; human; 1:1000; loading ...; fig 4a
In order to elucidate the mechanisms of interferon gamma-mediated bacterial translocation across human colonic epithelial monolayers, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on human samples at 1:250 (fig 4b) and in western blot on human samples at 1:1000 (fig 4a). Gastroenterology (2005) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; rat; 1:100; fig 1
  • western blot; African green monkey; fig 4
  • western blot; dogs; fig 1
  • western blot; human; fig 4
  • western blot; hamsters; fig 4
In order to test if HDAC inhibitors affect the expression of tight junction proteins, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on rat samples at 1:100 (fig 1), in western blot on African green monkey samples (fig 4), in western blot on dogs samples (fig 1), in western blot on human samples (fig 4) and in western blot on hamsters samples (fig 4). Mol Cancer Res (2004) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; 1:100; fig 3
In order to examine the expression and function of tight junctions in the epithelium of human palatine tonsils from patients with tonsillar hypertrophy or recurrent tonsillitis, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 3). J Histochem Cytochem (2004) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; dogs; loading ...; fig 1
In order to assess the effect of 50-Hz magnetic field exposures on the subcellular distribution of proteins found in adherens and tight junctions, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunohistochemistry on dogs samples (fig 1). ScientificWorldJournal (2004) ncbi
mouse monoclonal (OC-3F10)
  • immunoprecipitation; human; fig 9
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 7
In order to investigate the effects of estrogen on transcervical tight-junctional resistance, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunoprecipitation on human samples (fig 9), in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 7). J Clin Endocrinol Metab (2004) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; dogs; fig 8
In order to elucidate the localization of CEACAM1 isoforms, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunocytochemistry on dogs samples (fig 8). J Cell Sci (2004) ncbi
mouse monoclonal (OC-3F10)
  • western blot; human; fig 1b
In order to discuss the effects on tight junctions due to compression therapy, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in western blot on human samples (fig 1b). J Invest Dermatol (2003) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2c
In order to examine tight junction protein expression and localization in synovial sarcoma samples, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2c). Mod Pathol (2004) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; fig 1
In order to discuss methods to study tight junctions, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunohistochemistry on human samples (fig 1). Br J Dermatol (2003) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; mouse; 1:1600
In order to determine the distribution of airway junctional complex proteins after antigen or lipopolysaccharide challenge, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunohistochemistry - frozen section on mouse samples at 1:1600. Am J Respir Cell Mol Biol (2002) ncbi
mouse monoclonal (OC-3F10)
  • immunocytochemistry; human
In order to review applications of epithelial cell culture in studies of drug transport, Invitrogen OCLN antibody (Zymed, 33-1500) was used in immunocytochemistry on human samples . Methods Mol Biol (2002) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry; human; 1:100; fig 1
In order to study CEACAM1 in prostate cancer samples, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunohistochemistry on human samples at 1:100 (fig 1). Hum Pathol (2002) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human; loading ...
In order to isolate and characterize a human breast epithelial cell line with stem cell properties, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunohistochemistry - frozen section on human samples . Genes Dev (2002) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - frozen section; human
In order to test if myoepithelial cells are required for the correct polarity of breast epithelial structures, Invitrogen OCLN antibody (Zymed, OC-3F10) was used in immunohistochemistry - frozen section on human samples . J Cell Sci (2002) ncbi
mouse monoclonal (OC-3F10)
  • immunohistochemistry - paraffin section; human; fig 2
  • western blot; human; fig 1
In order to test if tight junction antigens are present in adult and developing human epidermis, Invitrogen OCLN antibody (Zymed, 33?C1500) was used in immunohistochemistry - paraffin section on human samples (fig 2) and in western blot on human samples (fig 1). J Invest Dermatol (2001) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; human; 1:250; loading ...; fig 7a
Abcam OCLN antibody (Abcam, ab222691) was used in immunohistochemistry - frozen section on human samples at 1:250 (fig 7a). Brain (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 3c
Abcam OCLN antibody (Abcam, ab31721) was used in immunohistochemistry on mouse samples at 1:100 (fig 3c). Brain (2022) ncbi
domestic rabbit monoclonal (EPR20992)
  • immunohistochemistry; mouse; loading ...; fig 2l
Abcam OCLN antibody (Abcam, ab216327) was used in immunohistochemistry on mouse samples (fig 2l). Front Immunol (2021) ncbi
domestic rabbit monoclonal (EPR8208)
  • western blot; mouse; 1:1000; loading ...; fig 1e
  • western blot; human; loading ...; fig 2a
Abcam OCLN antibody (Abcam, ab167161) was used in western blot on mouse samples at 1:1000 (fig 1e) and in western blot on human samples (fig 2a). Oxid Med Cell Longev (2021) ncbi
domestic rabbit monoclonal (EPR20992)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 8a
Abcam OCLN antibody (Abcam, ab216327) was used in immunohistochemistry - paraffin section on mouse samples (fig 8a). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (EPR20992)
  • immunohistochemistry; mouse; loading ...
Abcam OCLN antibody (Abcam, ab216327) was used in immunohistochemistry on mouse samples . JHEP Rep (2021) ncbi
domestic rabbit monoclonal (EPR20992)
  • immunohistochemistry - frozen section; rat; 1:100; loading ...; fig 5e
  • western blot; rat; loading ...; fig 5f
Abcam OCLN antibody (Abcam, ab216327) was used in immunohistochemistry - frozen section on rat samples at 1:100 (fig 5e) and in western blot on rat samples (fig 5f). Front Pharmacol (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:2000; loading ...; fig 2j
Abcam OCLN antibody (Abcam, ab31721) was used in western blot on mouse samples at 1:2000 (fig 2j). Front Immunol (2020) ncbi
domestic rabbit polyclonal
  • western blot; pigs ; loading ...; fig 1d
Abcam OCLN antibody (Abcam, ab31721) was used in western blot on pigs samples (fig 1d). Animals (Basel) (2020) ncbi
domestic rabbit monoclonal (EPR8208)
  • western blot; mouse; 1:1000; loading ...; fig 7i
Abcam OCLN antibody (Abcam, ab167161) was used in western blot on mouse samples at 1:1000 (fig 7i). Nat Commun (2020) ncbi
domestic rabbit monoclonal (EPR8208)
  • western blot; mouse; loading ...; fig 2f, 4a
Abcam OCLN antibody (Abcam, ab167161) was used in western blot on mouse samples (fig 2f, 4a). J Neuroinflammation (2020) ncbi
domestic rabbit monoclonal (EPR8208)
  • immunohistochemistry - frozen section; mouse; 1:4000; loading ...; fig 2c
Abcam OCLN antibody (Abcam, ab167161) was used in immunohistochemistry - frozen section on mouse samples at 1:4000 (fig 2c). elife (2019) ncbi
domestic rabbit monoclonal (EPR20992)
  • western blot; mouse; loading ...; fig 2c
Abcam OCLN antibody (Abcam, ab216327) was used in western blot on mouse samples (fig 2c). Cell Mol Gastroenterol Hepatol (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 5d
Abcam OCLN antibody (Abcam, ab31721) was used in western blot on mouse samples (fig 5d). Dis Model Mech (2018) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig 6c
In order to characterize the differentiation of RPE cells, Abcam OCLN antibody (Abcam, ab31721) was used in immunocytochemistry on human samples (fig 6c). Stem Cell Res Ther (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3d
Abcam OCLN antibody (Abcam, ab31721) was used in immunohistochemistry - paraffin section on mouse samples (fig 3d). Histochem Cell Biol (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 1:50; fig 8c
In order to develop a novel method for obtaining perivascular-resident macrophage-like melanocytes, pericytes, and endothelial cells primary cells to study the vestibular blood-labyrinth barrier, Abcam OCLN antibody (Abcam, Ab31721) was used in immunocytochemistry on mouse samples at 1:50 (fig 8c). Hear Res (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:250; loading ...; fig 3e
In order to test if D1-like receptors regulate duodenal permeability, Abcam OCLN antibody (Abcam, ab31721) was used in western blot on human samples at 1:250 (fig 3e). Acta Physiol (Oxf) (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 8a
In order to investigate the effects of tetrahydrocannabinol on bronchial epithelial cell permeability after exposure to TNF-alpha, Abcam OCLN antibody (Abcam, ab31721) was used in western blot on human samples (fig 8a). Biochem Pharmacol (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:250; loading ...; fig 7a
In order to assess the effects of dietary protein using a model of colitis, Abcam OCLN antibody (Abcam, ab31721) was used in western blot on mouse samples at 1:250 (fig 7a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:100; loading ...; fig 4
In order to investigate puerarin transport in a nasal mucosa model, Abcam OCLN antibody (Abcam, ab31721) was used in immunocytochemistry on human samples at 1:100 (fig 4). Drug Des Devel Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 6
Abcam OCLN antibody (Abcam, ab31721) was used in western blot on mouse samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 3
In order to study prevention of allergic skin disease by epidermal RAF, Abcam OCLN antibody (Abcam, ab31721) was used in western blot on mouse samples at 1:1000 (fig 3). elife (2016) ncbi
domestic rabbit polyclonal
  • western blot; pigs ; 1:250; fig 6b
Abcam OCLN antibody (Abcam, ab31721) was used in western blot on pigs samples at 1:250 (fig 6b). Vet Res (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; rat; 1:50; loading ...; fig 1c
  • western blot; rat; 1:500; loading ...; fig 3b
In order to elucidate how miR-21-5p alleviates traumatic brain injury in rats, Abcam OCLN antibody (Abcam, ab31721) was used in immunohistochemistry on rat samples at 1:50 (fig 1c) and in western blot on rat samples at 1:500 (fig 3b). Brain Res (2016) ncbi
domestic rabbit monoclonal (EPR8208)
  • ELISA; mouse; 1:1000; fig 4
Abcam OCLN antibody (abcam, ab167161) was used in ELISA on mouse samples at 1:1000 (fig 4). Front Neurosci (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:100; fig 6
Abcam OCLN antibody (abcam, ab31721) was used in immunocytochemistry on human samples at 1:100 (fig 6). Virol J (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:100; fig 4
  • western blot; human; 1:500; fig 4
In order to study the prevention of amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1 by MicroRNA-107, Abcam OCLN antibody (Abcam, Ab31721) was used in immunocytochemistry on human samples at 1:100 (fig 4) and in western blot on human samples at 1:500 (fig 4). Exp Cell Res (2016) ncbi
domestic rabbit monoclonal (EPR8208)
  • western blot; mouse; loading ...; fig 5k
In order to determine the effects of an altered intestinal microbiota and microbial metabolites on graft-versus-host disease, Abcam OCLN antibody (abcam, EPR8208) was used in western blot on mouse samples (fig 5k). Nat Immunol (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; fig s2
Abcam OCLN antibody (Abcam, ab31721) was used in immunocytochemistry on mouse samples (fig s2). Nat Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; fig 3
In order to assess regulation of blood-brain barrier permeability via Tie-2 after permanent middle cerebral artery occlusion in rats due to MicroRNA-150, Abcam OCLN antibody (Abcam, ab31721) was used in western blot on rat samples at 1:1000 (fig 3). FASEB J (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 7
In order to research an increase in human airway epithelial cell permeability through an arachidonic acid metabolite caused by the endogenous cannabinoid anandamide, Abcam OCLN antibody (Abcam, ab31721) was used in western blot on human samples at 1:1000 (fig 7). Pharmacol Res (2016) ncbi
domestic rabbit monoclonal (EPR8208)
  • western blot; rat; 1:1000; fig 7
In order to analyze EP1 prostanoid receptor in blood-brain barrier damage and their role in ischemic stroke, Abcam OCLN antibody (Abcam, ab167161) was used in western blot on rat samples at 1:1000 (fig 7). Sci Rep (2015) ncbi
domestic rabbit monoclonal (EPR8208)
  • immunohistochemistry; mouse; 1:50; fig 1d
  • western blot; mouse; 1:1000; fig 5f
Abcam OCLN antibody (Epitomics (now Abcam), ab167161) was used in immunohistochemistry on mouse samples at 1:50 (fig 1d) and in western blot on mouse samples at 1:1000 (fig 5f). Endocrinology (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (E-5)
  • immunohistochemistry; mouse; 1:600; loading ...; fig 6b
Santa Cruz Biotechnology OCLN antibody (Santa cruz, sc-133256) was used in immunohistochemistry on mouse samples at 1:600 (fig 6b). Ann Clin Transl Neurol (2022) ncbi
mouse monoclonal (F-11)
  • western blot; mouse; 1:100; loading ...; fig 5j
Santa Cruz Biotechnology OCLN antibody (Santa Cruz, sc-133255) was used in western blot on mouse samples at 1:100 (fig 5j). Nutrients (2021) ncbi
mouse monoclonal (E-5)
  • immunocytochemistry; human; 1:100; loading ...; fig 6c
Santa Cruz Biotechnology OCLN antibody (Santa, SC-133256) was used in immunocytochemistry on human samples at 1:100 (fig 6c). Front Immunol (2020) ncbi
mouse monoclonal (F-7)
  • western blot; rat; 1:500; loading ...; fig 5b
Santa Cruz Biotechnology OCLN antibody (Santa Cruz Biotechnology, sc-271842) was used in western blot on rat samples at 1:500 (fig 5b). Mol Med Rep (2017) ncbi
mouse monoclonal (F-11)
  • western blot; human; 1:200; loading ...; fig 1d
Santa Cruz Biotechnology OCLN antibody (SantaCruz, sc-133255) was used in western blot on human samples at 1:200 (fig 1d). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (E-5)
  • western blot; human; 1:200; loading ...; fig 4c
Santa Cruz Biotechnology OCLN antibody (SantaCruz, sc-133256) was used in western blot on human samples at 1:200 (fig 4c). Oncotarget (2016) ncbi
mouse monoclonal (E-5)
  • immunohistochemistry - paraffin section; mouse; 1:100
Santa Cruz Biotechnology OCLN antibody (Santa Cruz Biotechnology, sc-133256) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Exp Ther Med (2015) ncbi
mouse monoclonal (E-5)
  • western blot; mouse; 1:500; fig 5
In order to test if increasing dietary lipid consumption results in increased endotoxemia, low-grade inflammation, and metabolic and intestinal alterations, Santa Cruz Biotechnology OCLN antibody (santa cruz, sc- 133256) was used in western blot on mouse samples at 1:500 (fig 5). Nutr Res (2015) ncbi
mouse monoclonal (F-11)
  • immunocytochemistry; human; fig s1a
In order to develop methods to measure insulin transcytosis across individual, primary human adipose microvascular endothelial cells, Santa Cruz Biotechnology OCLN antibody (Santa Cruz, F-11) was used in immunocytochemistry on human samples (fig s1a). Mol Biol Cell (2015) ncbi
mouse monoclonal (E-5)
  • western blot; mouse; 1:1000
In order to determine the metabolic outcomes of cows fed high fat diet, Santa Cruz Biotechnology OCLN antibody (Santa Cruz, sc-133256) was used in western blot on mouse samples at 1:1000. Br J Nutr (2014) ncbi
mouse monoclonal (F-11)
  • western blot; human; 1:100
In order to study cord blood as a source of circulating endothelial progenitor cells that can be directed towards specialized endothelial phenotypes, Santa Cruz Biotechnology OCLN antibody (Santa Cruz Biotechnology, sc-133255) was used in western blot on human samples at 1:100. PLoS ONE (2014) ncbi
Novus Biologicals
domestic rabbit polyclonal (6F12-H4)
  • immunohistochemistry; mouse; 1:600; loading ...; fig 5b
Novus Biologicals OCLN antibody (Novus, NBP1-87402) was used in immunohistochemistry on mouse samples at 1:600 (fig 5b). Eur J Nutr (2020) ncbi
domestic rabbit polyclonal (6F12-H4)
  • immunohistochemistry - paraffin section; mouse; 1:600; loading ...; fig 3a
Novus Biologicals OCLN antibody (Novus, NBP1-87402) was used in immunohistochemistry - paraffin section on mouse samples at 1:600 (fig 3a). Int J Mol Sci (2020) ncbi
Articles Reviewed
  1. Hamdi L, Nabat H, Goldberg Y, Fainstein N, Segal S, Mediouni E, et al. Exercise training alters autoimmune cell invasion into the brain in autoimmune encephalomyelitis. Ann Clin Transl Neurol. 2022;9:1792-1806 pubmed publisher
  2. Cegarra C, Cameron B, Chaves C, Dabdoubi T, Do T, Gen xea t B, et al. An innovative strategy to identify new targets for delivering antibodies to the brain has led to the exploration of the integrin family. PLoS ONE. 2022;17:e0274667 pubmed publisher
  3. Ali M, Falkenhain K, Njiru B, Murtaza Ali M, Ruiz Uribe N, Haft Javaherian M, et al. VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer's mice. Brain. 2022;145:1449-1463 pubmed publisher
  4. Sasson E, Anzi S, Bell B, Yakovian O, Zorsky M, Deutsch U, et al. Nano-scale architecture of blood-brain barrier tight-junctions. elife. 2021;10: pubmed publisher
  5. Deng F, Hu J, Yang X, Sun Q, Lin Z, Zhao B, et al. Gut Microbial Metabolite Pravastatin Attenuates Intestinal Ischemia/Reperfusion Injury Through Promoting IL-13 Release From Type II Innate Lymphoid Cells via IL-33/ST2 Signaling. Front Immunol. 2021;12:704836 pubmed publisher
  6. Watanabe D, Nakagawa S, Morofuji Y, Tóth A, Vastag M, Aruga J, et al. Characterization of a Primate Blood-Brain Barrier Co-Culture Model Prepared from Primary Brain Endothelial Cells, Pericytes and Astrocytes. Pharmaceutics. 2021;13: pubmed publisher
  7. Zhang Z, Zhang L, Zhang Q, Liu B, Li F, Xin Y, et al. HO-1/CO Maintains Intestinal Barrier Integrity through NF-κB/MLCK Pathway in Intestinal HO-1-/- Mice. Oxid Med Cell Longev. 2021;2021:6620873 pubmed publisher
  8. Jiang D, Zhang J, Lin S, Wang Y, Chen Y, Fan J. Prolyl Endopeptidase Gene Disruption Improves Gut Dysbiosis and Non-alcoholic Fatty Liver Disease in Mice Induced by a High-Fat Diet. Front Cell Dev Biol. 2021;9:628143 pubmed publisher
  9. Fayad R, Rojas M, Partisani M, Finetti P, Dib S, Abélanet S, et al. EFA6B regulates a stop signal for collective invasion in breast cancer. Nat Commun. 2021;12:2198 pubmed publisher
  10. Sun Y, Wu D, Zeng W, Chen Y, Guo M, Lu B, et al. The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis. Front Cell Infect Microbiol. 2021;11:618265 pubmed publisher
  11. Ngamsri K, Gamper Tsigaras J, Reutershan J, Konrad F. Fractalkine Is Linked to the Necrosome Pathway in Acute Pulmonary Inflammation. Front Med (Lausanne). 2021;8:591790 pubmed publisher
  12. Tang X, Wang W, Hong G, Duan C, Zhu S, Tian Y, et al. Gut microbiota-mediated lysophosphatidylcholine generation promotes colitis in intestinal epithelium-specific Fut2 deficiency. J Biomed Sci. 2021;28:20 pubmed publisher
  13. Antonuccio P, Marini H, Micali A, Romeo C, Granese R, Retto A, et al. The Nutraceutical N-Palmitoylethanolamide (PEA) Reveals Widespread Molecular Effects Unmasking New Therapeutic Targets in Murine Varicocele. Nutrients. 2021;13: pubmed publisher
  14. Spatz M, Ciocan D, Merlen G, Rainteau D, Humbert L, Gomes Rochette N, et al. Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis. JHEP Rep. 2021;3:100230 pubmed publisher
  15. Guan Y, Chen K, Quan D, Kang L, Yang D, Wu H, et al. The Combination of Scutellaria baicalensis Georgi and Sophora japonica L. ameliorate Renal Function by Regulating Gut Microbiota in Spontaneously Hypertensive Rats. Front Pharmacol. 2020;11:575294 pubmed publisher
  16. Nikolakopoulou A, Wang Y, Ma Q, Sagare A, Montagne A, Huuskonen M, et al. Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A. J Exp Med. 2021;218: pubmed publisher
  17. Gong Y, Jin X, Yuan B, Lv Y, Yan G, Liu M, et al. G Protein-Coupled Receptor 109A Maintains the Intestinal Integrity and Protects Against ETEC Mucosal Infection by Promoting IgA Secretion. Front Immunol. 2020;11:583652 pubmed publisher
  18. Tian M, Chen J, Wu Z, Song H, Yang F, Cui C, et al. Fat Encapsulation Reduces Diarrhea in Piglets Partially by Repairing the Intestinal Barrier and Improving Fatty Acid Transport. Animals (Basel). 2020;11: pubmed publisher
  19. Vita S, Redell J, Maynard M, Zhao J, Grill R, Dash P, et al. P-glycoprotein Expression Is Upregulated in a Pre-Clinical Model of Traumatic Brain Injury. Neurotrauma Rep. 2020;1:207-217 pubmed publisher
  20. Devraj G, Guérit S, Seele J, Spitzer D, Macas J, Khel M, et al. HIF-1α is involved in blood-brain barrier dysfunction and paracellular migration of bacteria in pneumococcal meningitis. Acta Neuropathol. 2020;140:183-208 pubmed publisher
  21. Peroutka R, Buzza M, Mukhopadhyay S, Johnson T, Driesbaugh K, Antalis T. Testisin/Prss21 deficiency causes increased vascular permeability and a hemorrhagic phenotype during luteal angiogenesis. PLoS ONE. 2020;15:e0234407 pubmed publisher
  22. Kang L, Yu H, Yang X, Zhu Y, Bai X, Wang R, et al. Neutrophil extracellular traps released by neutrophils impair revascularization and vascular remodeling after stroke. Nat Commun. 2020;11:2488 pubmed publisher
  23. Matsubara J, Tian Y, Cui J, Zeglinski M, Hiroyasu S, Turner C, et al. Retinal Distribution and Extracellular Activity of Granzyme B: A Serine Protease That Degrades Retinal Pigment Epithelial Tight Junctions and Extracellular Matrix Proteins. Front Immunol. 2020;11:574 pubmed publisher
  24. Shi H, Wang Q, Zheng M, Hao S, Lum J, Chen X, et al. Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice. J Neuroinflammation. 2020;17:77 pubmed publisher
  25. Hu H, Hone E, Provencher E, Sprowls S, Farooqi I, Corbin D, et al. MiR-34a Interacts with Cytochrome c and Shapes Stroke Outcomes. Sci Rep. 2020;10:3233 pubmed publisher
  26. Shinde T, Perera A, Vemuri R, Gondalia S, Beale D, Karpe A, et al. Synbiotic supplementation with prebiotic green banana resistant starch and probiotic Bacillus coagulans spores ameliorates gut inflammation in mouse model of inflammatory bowel diseases. Eur J Nutr. 2020;: pubmed publisher
  27. Ear J, Saklecha A, Rajapakse N, Choi J, Ghassemian M, Kufareva I, et al. Tyrosine-Based Signals Regulate the Assembly of Daple⋅PARD3 Complex at Cell-Cell Junctions. iScience. 2020;23:100859 pubmed publisher
  28. Shastri S, Shinde T, Sohal S, Gueven N, Eri R. Idebenone Protects against Acute Murine Colitis via Antioxidant and Anti-Inflammatory Mechanisms. Int J Mol Sci. 2020;21: pubmed publisher
  29. Xing T, Benderman L, Sabu S, Parker J, Yang J, Lu Q, et al. Tight Junction Protein Claudin-7 Is Essential for Intestinal Epithelial Stem Cell Self-Renewal and Differentiation. Cell Mol Gastroenterol Hepatol. 2020;9:641-659 pubmed publisher
  30. Bendriem R, Singh S, Aleem A, Antonetti D, Ross M. Tight junction protein occludin regulates progenitor Self-Renewal and survival in developing cortex. elife. 2019;8: pubmed publisher
  31. Wang R, Yu R, Zhu C, Lin H, Lu X, Wang H. Tubulin detyrosination promotes human trophoblast syncytium formation. J Mol Cell Biol. 2019;: pubmed publisher
  32. Benz F, Wichitnaowarat V, Lehmann M, Germano R, Mihova D, Macas J, et al. Low wnt/β-catenin signaling determines leaky vessels in the subfornical organ and affects water homeostasis in mice. elife. 2019;8: pubmed publisher
  33. Wang Y, Sabbagh M, Gu X, Rattner A, Williams J, Nathans J. Beta-catenin signaling regulates barrier-specific gene expression in circumventricular organ and ocular vasculatures. elife. 2019;8: pubmed publisher
  34. Kiyohara H, Sujino T, Teratani T, Miyamoto K, Arai M, Nomura E, et al. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells. Cell Mol Gastroenterol Hepatol. 2019;7:135-156 pubmed publisher
  35. DaSilva Arnold S, Kuo C, Davra V, Remache Y, Kim P, Fisher J, et al. ZEB2, a master regulator of the epithelial-mesenchymal transition, mediates trophoblast differentiation. Mol Hum Reprod. 2019;25:61-75 pubmed publisher
  36. Kim Y, Lee M, Gu H, Kim J, Jeong S, Yeo S, et al. HIF-1α activation in myeloid cells accelerates dextran sodium sulfate-induced colitis progression in mice. Dis Model Mech. 2018;11: pubmed publisher
  37. Suzuki S, Tanaka A, Nakamura H, Murayama T. Knockout of Ceramide Kinase Aggravates Pathological and Lethal Responses in Mice with Experimental Colitis. Biol Pharm Bull. 2018;41:797-805 pubmed publisher
  38. Rempe R, Hartz A, Soldner E, Sokola B, Alluri S, Abner E, et al. Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy. J Neurosci. 2018;38:4301-4315 pubmed publisher
  39. Hazim R, Karumbayaram S, Jiang M, Dimashkie A, Lopes V, Li D, et al. Differentiation of RPE cells from integration-free iPS cells and their cell biological characterization. Stem Cell Res Ther. 2017;8:217 pubmed publisher
  40. Katsumata O, Mori M, Sawane Y, Niimura T, Ito A, Okamoto H, et al. Cellular and subcellular localization of ADP-ribosylation factor 6 in mouse peripheral tissues. Histochem Cell Biol. 2017;148:577-596 pubmed publisher
  41. Yang A, Inamine T, Hochrath K, Chen P, Wang L, Llorente C, et al. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest. 2017;127:2829-2841 pubmed publisher
  42. Benedicto I, Lehmann G, Ginsberg M, Nolan D, Bareja R, Elemento O, et al. Concerted regulation of retinal pigment epithelium basement membrane and barrier function by angiocrine factors. Nat Commun. 2017;8:15374 pubmed publisher
  43. Yanagida K, Liu C, Faraco G, Galvani S, Smith H, Burg N, et al. Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. Proc Natl Acad Sci U S A. 2017;114:4531-4536 pubmed publisher
  44. Lapierre L, Manning E, Mitchell K, Caldwell C, Goldenring J. Interaction of phosphorylated Rab11-FIP2 with Eps15 regulates apical junction composition. Mol Biol Cell. 2017;28:1088-1100 pubmed publisher
  45. Tung K, Harakal J, Qiao H, Rival C, Li J, Paul A, et al. Egress of sperm autoantigen from seminiferous tubules maintains systemic tolerance. J Clin Invest. 2017;127:1046-1060 pubmed publisher
  46. Prasad S, Sajja R, Kaisar M, Park J, Villalba H, Liles T, et al. Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity. Redox Biol. 2017;12:58-69 pubmed publisher
  47. Ni Y, Teng T, Li R, Simonyi A, Sun G, Lee J. TNFα alters occludin and cerebral endothelial permeability: Role of p38MAPK. PLoS ONE. 2017;12:e0170346 pubmed publisher
  48. Zhang J, Chen S, Cai J, Hou Z, Wang X, Kachelmeier A, et al. Culture media-based selection of endothelial cells, pericytes, and perivascular-resident macrophage-like melanocytes from the young mouse vestibular system. Hear Res. 2017;345:10-22 pubmed publisher
  49. Kraya R, Komin A, Searson P. On Chip Bioelectric Impedance Spectroscopy Reveals the Effect of P-Glycoprotein Efflux Pumps on the Paracellular Impedance of Tight Junctions at the Blood-Brain Barrier. IEEE Trans Nanobioscience. 2016;15:697-703 pubmed publisher
  50. Sivagurunathan S, Palanisamy K, Arunachalam J, Chidambaram S. Possible role of HIWI2 in modulating tight junction proteins in retinal pigment epithelial cells through Akt signaling pathway. Mol Cell Biochem. 2017;427:145-156 pubmed publisher
  51. Cao X, Shen L, Wu S, Yan C, Zhou Y, Xiong G, et al. Urban fine particulate matter exposure causes male reproductive injury through destroying blood-testis barrier (BTB) integrity. Toxicol Lett. 2017;266:1-12 pubmed publisher
  52. Zhang H, Zhang P, Gao Y, Li C, Wang H, Chen L, et al. Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs. Mol Med Rep. 2017;15:57-64 pubmed publisher
  53. Capra J, Eskelinen S. MDCK cells are capable of water secretion and reabsorption in response to changes in the ionic environment. Can J Physiol Pharmacol. 2017;95:72-83 pubmed publisher
  54. Hurtado Alvarado G, Dominguez Salazar E, Velazquez Moctezuma J, Gómez González B. A2A Adenosine Receptor Antagonism Reverts the Blood-Brain Barrier Dysfunction Induced by Sleep Restriction. PLoS ONE. 2016;11:e0167236 pubmed publisher
  55. Lin Z, Zhang Y, Xia Y, Xu X, Jiao X, Sun J. Salmonella enteritidis Effector AvrA Stabilizes Intestinal Tight Junctions via the JNK Pathway. J Biol Chem. 2016;291:26837-26849 pubmed publisher
  56. Martínez Rendón J, Sánchez Guzmán E, Rueda A, González J, Gulias Cañizo R, Aquino Jarquin G, et al. TRPV4 Regulates Tight Junctions and Affects Differentiation in a Cell Culture Model of the Corneal Epithelium. J Cell Physiol. 2017;232:1794-1807 pubmed publisher
  57. Chehaibi K, le Maire L, Bradoni S, Escolà J, Blanco Vaca F, Slimane M. Effect of PPAR-β/δ agonist GW0742 treatment in the acute phase response and blood-brain barrier permeability following brain injury. Transl Res. 2017;182:27-48 pubmed publisher
  58. Majka G, Wiecek G, Sróttek M, Spiewak K, Brindell M, Koziel J, et al. The impact of lactoferrin with different levels of metal saturation on the intestinal epithelial barrier function and mucosal inflammation. Biometals. 2016;29:1019-1033 pubmed
  59. Keppner A, Malsure S, Nobile A, Auberson M, Bonny O, Hummler E. Altered Prostasin (CAP1/Prss8) Expression Favors Inflammation and Tissue Remodeling in DSS-induced Colitis. Inflamm Bowel Dis. 2016;22:2824-2839 pubmed
  60. Mendonça M, Soares E, de Jesus M, Ceragioli H, Batista Ã, Nyúl Tóth Ã, et al. PEGylation of Reduced Graphene Oxide Induces Toxicity in Cells of the Blood-Brain Barrier: An in Vitro and in Vivo Study. Mol Pharm. 2016;13:3913-3924 pubmed
  61. Xiong J, Zhou M, Wang Y, Chen L, Xu W, Wang Y, et al. Protein Kinase D2 Protects against Acute Colitis Induced by Dextran Sulfate Sodium in Mice. Sci Rep. 2016;6:34079 pubmed publisher
  62. Feng X, Zhang D, Wang Y, Fan R, Hong F, Zhang Y, et al. Dopamine enhances duodenal epithelial permeability via the dopamine D5 receptor in rodent. Acta Physiol (Oxf). 2017;220:113-123 pubmed publisher
  63. Shang V, Kendall D, Roberts R. ?9-Tetrahydrocannabinol reverses TNF?-induced increase in airway epithelial cell permeability through CB2 receptors. Biochem Pharmacol. 2016;120:63-71 pubmed publisher
  64. Kuan W, Bennett N, He X, Skepper J, Martynyuk N, Wijeyekoon R, et al. ?-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function. Exp Neurol. 2016;285:72-81 pubmed publisher
  65. Springler A, Hessenberger S, Schatzmayr G, Mayer E. Early Activation of MAPK p44/42 Is Partially Involved in DON-Induced Disruption of the Intestinal Barrier Function and Tight Junction Network. Toxins (Basel). 2016;8: pubmed publisher
  66. Qian Y, Li C, Jiang A, Ge S, Gu P, Fan X, et al. HIV-1 gp120 Glycoprotein Interacting with Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN) Down-Regulates Tight Junction Proteins to Disrupt the Blood Retinal Barrier and Increase Its Permeability. J Biol Chem. 2016;291:22977-22987 pubmed
  67. Ahn C, Shin D, Lee D, Kang S, Seok J, Kang H, et al. Expression of claudins, occludin, junction adhesion molecule A and zona occludens 1 in canine organs. Mol Med Rep. 2016;14:3697-703 pubmed publisher
  68. de Sousa Rodrigues M, Bekhbat M, Houser M, Chang J, Walker D, Jones D, et al. Chronic psychological stress and high-fat high-fructose diet disrupt metabolic and inflammatory gene networks in the brain, liver, and gut and promote behavioral deficits in mice. Brain Behav Immun. 2017;59:158-172 pubmed publisher
  69. Lan A, Blais A, Coelho D, Capron J, Maarouf M, Benamouzig R, et al. Dual effects of a high-protein diet on DSS-treated mice during colitis resolution phase. Am J Physiol Gastrointest Liver Physiol. 2016;311:G624-G633 pubmed publisher
  70. Li N, Lee W, Cheng C. Overexpression of plastin 3 in Sertoli cells disrupts actin microfilament bundle homeostasis and perturbs the tight junction barrier. Spermatogenesis. 2016;6:e1206353 pubmed publisher
  71. Wardill H, Bowen J, Van Sebille Y, Secombe K, Coller J, Ball I, et al. TLR4-Dependent Claudin-1 Internalization and Secretagogue-Mediated Chloride Secretion Regulate Irinotecan-Induced Diarrhea. Mol Cancer Ther. 2016;15:2767-2779 pubmed
  72. Ronaghan N, Shang J, Iablokov V, Zaheer R, Colarusso P, Dion S, et al. The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction. Am J Physiol Gastrointest Liver Physiol. 2016;311:G466-79 pubmed publisher
  73. Stammler A, Lüftner B, Kliesch S, Weidner W, Bergmann M, Middendorff R, et al. Highly Conserved Testicular Localization of Claudin-11 in Normal and Impaired Spermatogenesis. PLoS ONE. 2016;11:e0160349 pubmed publisher
  74. Zhang L, Du S, Lu Y, Liu C, Tian Z, Yang C, et al. Puerarin transport across a Calu-3 cell monolayer - an in vitro model of nasal mucosa permeability and the influence of paeoniflorin and menthol. Drug Des Devel Ther. 2016;10:2227-37 pubmed publisher
  75. Pang J, Wu Y, Peng J, Yang P, Kuai L, Qin X, et al. Potential implications of Apolipoprotein E in early brain injury after experimental subarachnoid hemorrhage: Involvement in the modulation of blood-brain barrier integrity. Oncotarget. 2016;7:56030-56044 pubmed publisher
  76. Zeller P, Legendre A, Jacques S, Fleury M, Gilard F, Tcherkez G, et al. Hepatocytes cocultured with Sertoli cells in bioreactor favors Sertoli barrier tightness in rat. J Appl Toxicol. 2017;37:287-295 pubmed publisher
  77. Li N, Mruk D, Chen H, Wong C, Lee W, Cheng C. Rescue of perfluorooctanesulfonate (PFOS)-mediated Sertoli cell injury by overexpression of gap junction protein connexin 43. Sci Rep. 2016;6:29667 pubmed publisher
  78. Raguz J, Jerić I, Niault T, Nowacka J, Kuzet S, Rupp C, et al. Epidermal RAF prevents allergic skin disease. elife. 2016;5: pubmed publisher
  79. Zhang Z, Yan J, Shi H. Role of Hypoxia Inducible Factor 1 in Hyperglycemia-Exacerbated Blood-Brain Barrier Disruption in Ischemic Stroke. Neurobiol Dis. 2016;95:82-92 pubmed publisher
  80. Yang G, Zhu Y, Zhang W, Zhou D, Zhai C, Wang J. Influence of orally fed a select mixture of Bacillus probiotics on intestinal T-cell migration in weaned MUC4 resistant pigs following Escherichia coli challenge. Vet Res. 2016;47:71 pubmed publisher
  81. Clark P, Al Ahmad A, Qian T, Zhang R, Wilson H, Weichert J, et al. Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model. Mol Pharm. 2016;13:3341-9 pubmed publisher
  82. Ge X, Huang S, Gao H, Han Z, Chen F, Zhang S, et al. miR-21-5p alleviates leakage of injured brain microvascular endothelial barrier in vitro through suppressing inflammation and apoptosis. Brain Res. 2016;1650:31-40 pubmed publisher
  83. Stremmel W, Staffer S, Gan Schreier H, Wannhoff A, Bach M, Gauss A. Phosphatidylcholine passes through lateral tight junctions for paracellular transport to the apical side of the polarized intestinal tumor cell-line CaCo2. Biochim Biophys Acta. 2016;1861:1161-1169 pubmed publisher
  84. Gao Y, Lui W, Lee W, Cheng C. Polarity protein Crumbs homolog-3 (CRB3) regulates ectoplasmic specialization dynamics through its action on F-actin organization in Sertoli cells. Sci Rep. 2016;6:28589 pubmed publisher
  85. Campos Y, Qiu X, Gomero E, Wakefield R, Horner L, Brutkowski W, et al. Alix-mediated assembly of the actomyosin-tight junction polarity complex preserves epithelial polarity and epithelial barrier. Nat Commun. 2016;7:11876 pubmed publisher
  86. Löffler T, Flunkert S, Temmel M, Hutter Paier B. Decreased Plasma A? in Hyperlipidemic APPSL Transgenic Mice Is Associated with BBB Dysfunction. Front Neurosci. 2016;10:232 pubmed publisher
  87. Rodriguez M, Kaushik A, Lapierre J, Dever S, El Hage N, Nair M. Electro-Magnetic Nano-Particle Bound Beclin1 siRNA Crosses the Blood-Brain Barrier to Attenuate the Inflammatory Effects of HIV-1 Infection in Vitro. J Neuroimmune Pharmacol. 2017;12:120-132 pubmed publisher
  88. Wang X, Fan F, Cao Q. Modified Pulsatilla decoction attenuates oxazolone-induced colitis in mice through suppression of inflammation and epithelial barrier disruption. Mol Med Rep. 2016;14:1173-9 pubmed publisher
  89. Lee S, Kim H, Kim K, Lee H, Lee S, Lee D. Arhgap17, a RhoGTPase activating protein, regulates mucosal and epithelial barrier function in the mouse colon. Sci Rep. 2016;6:26923 pubmed publisher
  90. Lehner C, Gehwolf R, Ek J, Korntner S, Bauer H, Bauer H, et al. The blood-tendon barrier: identification and characterisation of a novel tissue barrier in tendon blood vessels. Eur Cell Mater. 2016;31:296-311 pubmed
  91. Poon C, Madawala R, Dowland S, Murphy C. Nectin-3 Is Increased in the Cell Junctions of the Uterine Epithelium at Implantation. Reprod Sci. 2016;23:1580-1592 pubmed
  92. Xu S, Xue X, You K, Fu J. Caveolin-1 regulates the expression of tight junction proteins during hyperoxia-induced pulmonary epithelial barrier breakdown. Respir Res. 2016;17:50 pubmed publisher
  93. Teo W, Merino V, Cho S, Korangath P, Liang X, Wu R, et al. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24. Oncogene. 2016;35:5539-5551 pubmed publisher
  94. Vorvis C, Hatziapostolou M, Mahurkar Joshi S, Koutsioumpa M, Williams J, Donahue T, et al. Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. Am J Physiol Gastrointest Liver Physiol. 2016;310:G1124-37 pubmed publisher
  95. Kobayashi K, Tsugami Y, Matsunaga K, Oyama S, Kuki C, Kumura H. Prolactin and glucocorticoid signaling induces lactation-specific tight junctions concurrent with ?-casein expression in mammary epithelial cells. Biochim Biophys Acta. 2016;1863:2006-16 pubmed publisher
  96. Inada M, Izawa G, Kobayashi W, Ozawa M. 293 cells express both epithelial as well as mesenchymal cell adhesion molecules. Int J Mol Med. 2016;37:1521-7 pubmed publisher
  97. Liu S, Zhou F, Shen Y, Zhang Y, Yin H, Zeng Y, et al. Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells. Oncotarget. 2016;7:32876-92 pubmed publisher
  98. Guerrera D, Shah J, Vasileva E, Sluysmans S, Méan I, Jond L, et al. PLEKHA7 Recruits PDZD11 to Adherens Junctions to Stabilize Nectins. J Biol Chem. 2016;291:11016-29 pubmed publisher
  99. Sa Ngiamsuntorn K, Wongkajornsilp A, Phanthong P, Borwornpinyo S, Kitiyanant N, Chantratita W, et al. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host. Virol J. 2016;13:59 pubmed publisher
  100. Kwon J, Jeong S, Choi I, Kim N. ADAM10 Is Involved in Cell Junction Assembly in Early Porcine Embryo Development. PLoS ONE. 2016;11:e0152921 pubmed publisher
  101. Liu W, Cai H, Lin M, Zhu L, Gao L, Zhong R, et al. MicroRNA-107 prevents amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1. Exp Cell Res. 2016;343:248-257 pubmed publisher
  102. Wardill H, Gibson R, Van Sebille Y, Secombe K, Logan R, Bowen J. A novel in vitro platform for the study of SN38-induced mucosal damage and the development of Toll-like receptor 4-targeted therapeutic options. Exp Biol Med (Maywood). 2016;241:1386-94 pubmed publisher
  103. Yang C, Demars K, Hawkins K, Candelario Jalil E. Adropin reduces paracellular permeability of rat brain endothelial cells exposed to ischemia-like conditions. Peptides. 2016;81:29-37 pubmed publisher
  104. Mathewson N, Jenq R, Mathew A, Koenigsknecht M, Hanash A, Toubai T, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016;17:505-513 pubmed publisher
  105. Chen H, Mruk D, Lee W, Cheng C. Planar Cell Polarity (PCP) Protein Vangl2 Regulates Ectoplasmic Specialization Dynamics via Its Effects on Actin Microfilaments in the Testes of Male Rats. Endocrinology. 2016;157:2140-59 pubmed publisher
  106. Kacem M, Agili F, Tounsi H, Zribi H, Zaraa I, Mokni M, et al. Immunohistological study of tight junction protein expression in mal de Meleda. Ultrastruct Pathol. 2016;40:176-80 pubmed publisher
  107. Kuehn A, Kletting S, de Souza Carvalho Wodarz C, Repnik U, Griffiths G, Fischer U, et al. Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier. ALTEX. 2016;33:251-60 pubmed publisher
  108. Ji X, Liu Y, Hurd R, Wang J, Fitzmaurice B, Nishina P, et al. Retinal Pigment Epithelium Atrophy 1 (rpea1): A New Mouse Model With Retinal Detachment Caused by a Disruption of Protein Kinase C, θ. Invest Ophthalmol Vis Sci. 2016;57:877-88 pubmed publisher
  109. Shukla P, Chaudhry K, Mir H, Gangwar R, Yadav N, Manda B, et al. Chronic ethanol feeding promotes azoxymethane and dextran sulfate sodium-induced colonic tumorigenesis potentially by enhancing mucosal inflammation. BMC Cancer. 2016;16:189 pubmed publisher
  110. Jang C, Oh S, Wada S, Rowe G, Liu L, Chan M, et al. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat Med. 2016;22:421-6 pubmed publisher
  111. Strazielle N, Creidy R, Malcus C, Boucraut J, Ghersi Egea J. T-Lymphocytes Traffic into the Brain across the Blood-CSF Barrier: Evidence Using a Reconstituted Choroid Plexus Epithelium. PLoS ONE. 2016;11:e0150945 pubmed publisher
  112. Liu H, Garzoni L, Herry C, Durosier L, Cao M, Burns P, et al. Can Monitoring Fetal Intestinal Inflammation Using Heart Rate Variability Analysis Signal Incipient Necrotizing Enterocolitis of the Neonate?. Pediatr Crit Care Med. 2016;17:e165-76 pubmed publisher
  113. Fang Z, He Q, Li Q, Chen X, Baral S, Jin H, et al. MicroRNA-150 regulates blood-brain barrier permeability via Tie-2 after permanent middle cerebral artery occlusion in rats. FASEB J. 2016;30:2097-107 pubmed publisher
  114. Shirasago Y, Shimizu Y, Tanida I, Suzuki T, Suzuki R, Sugiyama K, et al. Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection. Biol Pharm Bull. 2016;39:839-48 pubmed publisher
  115. Ibrahim A, Mander S, Hussein K, Elsherbiny N, Smith S, Al Shabrawey M, et al. Hyperhomocysteinemia disrupts retinal pigment epithelial structure and function with features of age-related macular degeneration. Oncotarget. 2016;7:8532-45 pubmed publisher
  116. Sántha P, Veszelka S, Hoyk Z, Mészáros M, Walter F, Tóth A, et al. Restraint Stress-Induced Morphological Changes at the Blood-Brain Barrier in Adult Rats. Front Mol Neurosci. 2015;8:88 pubmed publisher
  117. Shang V, O Sullivan S, Kendall D, Roberts R. The endogenous cannabinoid anandamide increases human airway epithelial cell permeability through an arachidonic acid metabolite. Pharmacol Res. 2016;105:152-63 pubmed publisher
  118. Villarroel Espíndola F, Tapia C, González Stegmaier R, Concha I, Slebe J. Polyglucosan Molecules Induce Mitochondrial Impairment and Apoptosis in Germ Cells Without Affecting the Integrity and Functionality of Sertoli Cells. J Cell Physiol. 2016;231:2142-52 pubmed publisher
  119. Miquel S, Martín R, Lashermes A, Gillet M, Meleine M, Gelot A, et al. Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models. Sci Rep. 2016;6:19399 pubmed publisher
  120. Lou N, Takano T, Pei Y, Xavier A, Goldman S, Nedergaard M. Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier. Proc Natl Acad Sci U S A. 2016;113:1074-9 pubmed publisher
  121. Grozdanović M, ÄŒavić M, NeÅ¡ić A, Andjelković U, Akbari P, Smit J, et al. Kiwifruit cysteine protease actinidin compromises the intestinal barrier by disrupting tight junctions. Biochim Biophys Acta. 2016;1860:516-26 pubmed publisher
  122. Li N, Mruk D, Mok K, Li M, Wong C, Lee W, et al. Connexin 43 reboots meiosis and reseals blood-testis barrier following toxicant-mediated aspermatogenesis and barrier disruption. FASEB J. 2016;30:1436-52 pubmed publisher
  123. Shi Y, Liu T, Fu J, Xu W, Wu L, Hou A, et al. Vitamin D/VDR signaling attenuates lipopolysaccharide‑induced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier. Mol Med Rep. 2016;13:1186-94 pubmed publisher
  124. Kim H, Cronin M, Ahrens K, Papastavros V, Santoro D, Marsella R. A comparative study of epidermal tight junction proteins in a dog model of atopic dermatitis. Vet Dermatol. 2016;27:40-e11 pubmed publisher
  125. Arévalo Turrubiarte M, Perruchot M, Finot L, Mayeur F, Dessauge F. Phenotypic and functional characterization of two bovine mammary epithelial cell lines in 2D and 3D models. Am J Physiol Cell Physiol. 2016;310:C348-56 pubmed publisher
  126. Frankowski J, Demars K, Ahmad A, Hawkins K, Yang C, Leclerc J, et al. Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke. Sci Rep. 2015;5:17956 pubmed publisher
  127. Kessler M, Hoffmann K, Brinkmann V, Thieck O, Jackisch S, Toelle B, et al. The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids. Nat Commun. 2015;6:8989 pubmed publisher
  128. Nadeem A, Thomas P, Ulf M, Elena N, Anggakusuma A, Mohamed B, et al. Cell culture-derived HCV cannot infect synovial fibroblasts. Sci Rep. 2015;5:18043 pubmed publisher
  129. Castro V, Bertrand L, Luethen M, Dabrowski S, Lombardi J, Morgan L, et al. Occludin controls HIV transcription in brain pericytes via regulation of SIRT-1 activation. FASEB J. 2016;30:1234-46 pubmed publisher
  130. McCabe M, Foo C, Dinger M, Smooker P, Stanton P. Claudin-11 and occludin are major contributors to Sertoli cell tight junction function, in vitro. Asian J Androl. 2016;18:620-6 pubmed publisher
  131. Rodrigo Albors A, Tazaki A, Rost F, Nowoshilow S, Chara O, Tanaka E. Planar cell polarity-mediated induction of neural stem cell expansion during axolotl spinal cord regeneration. elife. 2015;4:e10230 pubmed publisher
  132. Stebbins M, Wilson H, Canfield S, Qian T, Palecek S, Shusta E. Differentiation and characterization of human pluripotent stem cell-derived brain microvascular endothelial cells. Methods. 2016;101:93-102 pubmed publisher
  133. Vandenhaute E, Stump Guthier C, Losada M, Tenenbaum T, Rudolph H, Ishikawa H, et al. The choroid plexus may be an underestimated site of tumor invasion to the brain: an in vitro study using neuroblastoma cell lines. Cancer Cell Int. 2015;15:102 pubmed publisher
  134. Freedman B, Brooks C, Lam A, Fu H, Morizane R, Agrawal V, et al. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat Commun. 2015;6:8715 pubmed publisher
  135. Kim C, Kim J, Jo K, Lee Y, Sohn E, Yoo N, et al. OSSC1E-K19, a novel phytochemical component of Osteomeles schwerinae, prevents glycated albumin-induced retinal vascular injury in rats. Mol Med Rep. 2015;12:7279-84 pubmed publisher
  136. Barbáchano A, Fernández Barral A, Pereira F, Segura M, Ordóñez Morán P, Carrillo de Santa Pau E, et al. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150. Oncogene. 2016;35:2991-3003 pubmed publisher
  137. Martínez Revollar G, Garay E, Martín Tapia D, Nava P, Huerta M, Lopez Bayghen E, et al. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Exp Cell Res. 2015;339:67-80 pubmed publisher
  138. Cravo A, Carter E, Erkan M, Harvey E, Furutani Seiki M, MRSNY R. Hippo pathway elements Co-localize with Occludin: A possible sensor system in pancreatic epithelial cells. Tissue Barriers. 2015;3:e1037948 pubmed publisher
  139. Wardill H, Logan R, Bowen J, Van Sebille Y, Gibson R. Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer. Support Care Cancer. 2016;24:1779-88 pubmed publisher
  140. Blume C, Reale R, Held M, Millar T, Collins J, Davies D, et al. Temporal Monitoring of Differentiated Human Airway Epithelial Cells Using Microfluidics. PLoS ONE. 2015;10:e0139872 pubmed publisher
  141. Lee J, Tato C, Joyce Shaikh B, Gulen M, Gulan F, Cayatte C, et al. Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability. Immunity. 2015;43:727-38 pubmed publisher
  142. Valere K, Rapista A, Eugenin E, Lu W, Chang T. Human Alpha-Defensin HNP1 Increases HIV Traversal of the Epithelial Barrier: A Potential Role in STI-Mediated Enhancement of HIV Transmission. Viral Immunol. 2015;28:609-15 pubmed publisher
  143. Brkic M, Balusu S, Van Wonterghem E, Gorlé N, Benilova I, Kremer A, et al. Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases. J Neurosci. 2015;35:12766-78 pubmed publisher
  144. Dong H, Chen Z, Wang C, Xiong Z, Zhao W, Jia C, et al. Rictor Regulates Spermatogenesis by Controlling Sertoli Cell Cytoskeletal Organization and Cell Polarity in the Mouse Testis. Endocrinology. 2015;156:4244-56 pubmed publisher
  145. Zhao Y, Zhao L, Wang P, Miao Y, Liu Y, Wang Z, et al. Overexpression of miR-18a negatively regulates myocyte enhancer factor 2D to increase the permeability of the blood-tumor barrier via Krüppel-like factor 4-mediated downregulation of zonula occluden-1, claudin-5, and occludin. J Neurosci Res. 2015;93:1891-902 pubmed publisher
  146. Janosevic D, Axis J, Bacallao R, Amsler K. Occludin Content Modulates Hydrogen Peroxide-Induced Increase in Renal Epithelial Paracellular Permeability. J Cell Biochem. 2016;117:769-79 pubmed publisher
  147. Liu S, Zhao J, Fan X, Liu G, Jiao H, Wang X, et al. Rapamycin, a specific inhibitor of the target of rapamycin complex 1, disrupts intestinal barrier integrity in broiler chicks. J Anim Physiol Anim Nutr (Berl). 2016;100:323-30 pubmed publisher
  148. Yuksel H, Yilmaz O, Karaman M, Fırıncı F, Turkeli A, Kanik E, et al. Vascular endothelial growth factor antagonism restores epithelial barrier dysfunction via affecting zonula occludens proteins. Exp Ther Med. 2015;10:362-368 pubmed
  149. Tan F, Fu W, Cheng N, Meng D, Gu Y. Ligustrazine reduces blood-brain barrier permeability in a rat model of focal cerebral ischemia and reperfusion. Exp Ther Med. 2015;9:1757-1762 pubmed
  150. Goichon A, Bertrand J, Chan P, Lecleire S, Coquard A, Cailleux A, et al. Enteral delivery of proteins enhances the expression of proteins involved in the cytoskeleton and protein biosynthesis in human duodenal mucosa. Am J Clin Nutr. 2015;102:359-67 pubmed publisher
  151. Chang C, Lin C, Lu C, Martel J, Ko Y, Ojcius D, et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun. 2015;6:7489 pubmed publisher
  152. Ek C, D Angelo B, Lehner C, Nathanielsz P, Li C, Mallard C. Expression of tight junction proteins and transporters for xenobiotic metabolism at the blood-CSF barrier during development in the nonhuman primate (P. hamadryas). Reprod Toxicol. 2015;56:32-44 pubmed publisher
  153. Morita S, Furube E, Mannari T, Okuda H, Tatsumi K, Wanaka A, et al. Heterogeneous vascular permeability and alternative diffusion barrier in sensory circumventricular organs of adult mouse brain. Cell Tissue Res. 2016;363:497-511 pubmed publisher
  154. Li N, Mruk D, Wong C, Lee W, Han D, Cheng C. Actin-bundling protein plastin 3 is a regulator of ectoplasmic specialization dynamics during spermatogenesis in the rat testis. FASEB J. 2015;29:3788-805 pubmed publisher
  155. Suárez Causado A, Caballero Díaz D, Bertrán E, Roncero C, Addante A, García Álvaro M, et al. HGF/c-Met signaling promotes liver progenitor cell migration and invasion by an epithelial-mesenchymal transition-independent, phosphatidyl inositol-3 kinase-dependent pathway in an in vitro model. Biochim Biophys Acta. 2015;1853:2453-63 pubmed publisher
  156. Abdayem R, Callejon S, Portes P, Kirilov P, Demarne F, Pirot F, et al. Modulation of transepithelial electric resistance (TEER) in reconstructed human epidermis by excipients known to permeate intestinal tight junctions. Exp Dermatol. 2015;24:686-91 pubmed publisher
  157. Son Y, Heo K, Bae M, Lee C, Cho W, Kim S, et al. Injury to the blood-testis barrier after low-dose-rate chronic radiation exposure in mice. Radiat Prot Dosimetry. 2015;167:316-20 pubmed publisher
  158. Cong X, Zhang Y, Li J, Mei M, Ding C, Xiang R, et al. Claudin-4 is required for modulation of paracellular permeability by muscarinic acetylcholine receptor in epithelial cells. J Cell Sci. 2015;128:2271-86 pubmed publisher
  159. Staat C, Coisne C, Dabrowski S, Stamatovic S, Andjelkovic A, Wolburg H, et al. Mode of action of claudin peptidomimetics in the transient opening of cellular tight junction barriers. Biomaterials. 2015;54:9-20 pubmed publisher
  160. Wu S, Yi J, Zhang Y, Zhou J, Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol Rep. 2015;3: pubmed publisher
  161. Pothoven K, Norton J, Hulse K, Suh L, Carter R, Rocci E, et al. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease. J Allergy Clin Immunol. 2015;136:737-746.e4 pubmed publisher
  162. Li F, Duggal R, Oliva O, Karki S, Surolia R, Wang Z, et al. Heme oxygenase-1 protects corexit 9500A-induced respiratory epithelial injury across species. PLoS ONE. 2015;10:e0122275 pubmed publisher
  163. Scull M, Shi C, De Jong Y, Gerold G, Ries M, von Schaewen M, et al. Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice. Hepatology. 2015;62:57-67 pubmed publisher
  164. Haarmann A, Nowak E, Deiß A, van der Pol S, Monoranu C, Kooij G, et al. Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling. Acta Neuropathol. 2015;129:639-52 pubmed publisher
  165. Bazellières E, Conte V, Elosegui Artola A, Serra Picamal X, Bintanel Morcillo M, Roca Cusachs P, et al. Control of cell-cell forces and collective cell dynamics by the intercellular adhesome. Nat Cell Biol. 2015;17:409-20 pubmed publisher
  166. Muramatsu R, Kuroda M, Matoba K, Lin H, Takahashi C, Koyama Y, et al. Prostacyclin prevents pericyte loss and demyelination induced by lysophosphatidylcholine in the central nervous system. J Biol Chem. 2015;290:11515-25 pubmed publisher
  167. Fredriksson K, Van Itallie C, Aponte A, Gucek M, Tietgens A, Anderson J. Proteomic analysis of proteins surrounding occludin and claudin-4 reveals their proximity to signaling and trafficking networks. PLoS ONE. 2015;10:e0117074 pubmed publisher
  168. Strick Marchand H, Dusséaux M, Darche S, Huntington N, Legrand N, Masse Ranson G, et al. A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS ONE. 2015;10:e0119820 pubmed publisher
  169. Lee J, Choi H, Na W, Ju B, Yune T. 17β-estradiol inhibits MMP-9 and SUR1/TrpM4 expression and activation and thereby attenuates BSCB disruption/hemorrhage after spinal cord injury in male rats. Endocrinology. 2015;156:1838-50 pubmed publisher
  170. Furihata T, Kawamatsu S, Ito R, Saito K, Suzuki S, Kishida S, et al. Hydrocortisone enhances the barrier properties of HBMEC/ciβ, a brain microvascular endothelial cell line, through mesenchymal-to-endothelial transition-like effects. Fluids Barriers CNS. 2015;12:7 pubmed publisher
  171. Boulay A, Mazeraud A, Cisternino S, Saubaméa B, Mailly P, Jourdren L, et al. Immune quiescence of the brain is set by astroglial connexin 43. J Neurosci. 2015;35:4427-39 pubmed publisher
  172. Sohet F, Lin C, Munji R, Lee S, Ruderisch N, Soung A, et al. LSR/angulin-1 is a tricellular tight junction protein involved in blood-brain barrier formation. J Cell Biol. 2015;208:703-11 pubmed publisher
  173. ErLin S, WenJie W, LiNing W, BingXin L, MingDe L, Yan S, et al. Musashi-1 maintains blood-testis barrier structure during spermatogenesis and regulates stress granule formation upon heat stress. Mol Biol Cell. 2015;26:1947-56 pubmed publisher
  174. Röhl M, Tjernlund A, Mehta S, Pettersson P, Bailey R, Broliden K. Comparable mRNA expression of inflammatory markers but lower claudin-1 mRNA levels in foreskin tissue of HSV-2 seropositive versus seronegative asymptomatic Kenyan young men. BMJ Open. 2015;5:e006627 pubmed publisher
  175. Benoit B, Laugerette F, Plaisancié P, Géloën A, Bodennec J, Estienne M, et al. Increasing fat content from 20 to 45 wt% in a complex diet induces lower endotoxemia in parallel with an increased number of intestinal goblet cells in mice. Nutr Res. 2015;35:346-56 pubmed publisher
  176. Momeny M, Saunus J, Marturana F, McCart Reed A, Black D, Sala G, et al. Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines. Oncotarget. 2015;6:3932-46 pubmed
  177. Chajra H, Amstutz B, Schweikert K, Auriol D, Redziniak G, Lefèvre F. Opioid receptor delta as a global modulator of skin differentiation and barrier function repair. Int J Cosmet Sci. 2015;37:386-94 pubmed publisher
  178. Ek C, D Angelo B, Baburamani A, Lehner C, Leverin A, Smith P, et al. Brain barrier properties and cerebral blood flow in neonatal mice exposed to cerebral hypoxia-ischemia. J Cereb Blood Flow Metab. 2015;35:818-27 pubmed publisher
  179. Peng H, Li C, Kadow S, Henry B, Steinmann J, Becker K, et al. Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis. J Mol Med (Berl). 2015;93:675-89 pubmed publisher
  180. Chen M, Yang T, Meng X, Sun T. Azithromycin attenuates cigarette smoke extract-induced oxidative stress injury in human alveolar epithelial cells. Mol Med Rep. 2015;11:3414-22 pubmed publisher
  181. Li Z, Liu Y, Liu X, Xue Y, Wang P, Liu L. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism. Exp Cell Res. 2015;331:257-66 pubmed publisher
  182. Lee S, Kwon J, Choi I, Kim N. Expression and function of transcription factor AP-2? in early embryonic development of porcine parthenotes. Reprod Fertil Dev. 2015;: pubmed publisher
  183. Kreft M, Jerman U, Lasič E, Hevir Kene N, Rižner T, Peternel L, et al. The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function. Eur J Pharm Sci. 2015;69:1-9 pubmed publisher
  184. Azizi P, Zyla R, Guan S, Wang C, Liu J, Bolz S, et al. Clathrin-dependent entry and vesicle-mediated exocytosis define insulin transcytosis across microvascular endothelial cells. Mol Biol Cell. 2015;26:740-50 pubmed publisher
  185. Nicolas V, Liévin Le Moal V. Antisecretory factor peptide AF-16 inhibits the secreted autotransporter toxin-stimulated transcellular and paracellular passages of fluid in cultured human enterocyte-like cells. Infect Immun. 2015;83:907-22 pubmed publisher
  186. Vitiello E, Ferreira J, Maiato H, Balda M, Matter K. The tumour suppressor DLC2 ensures mitotic fidelity by coordinating spindle positioning and cell-cell adhesion. Nat Commun. 2014;5:5826 pubmed publisher
  187. Watari A, Hashegawa M, Yagi K, Kondoh M. Homoharringtonine increases intestinal epithelial permeability by modulating specific claudin isoforms in Caco-2 cell monolayers. Eur J Pharm Biopharm. 2015;89:232-8 pubmed publisher
  188. Qiao X, Roth I, Féraille E, Hasler U. Different effects of ZO-1, ZO-2 and ZO-3 silencing on kidney collecting duct principal cell proliferation and adhesion. Cell Cycle. 2014;13:3059-75 pubmed publisher
  189. Fernandes S, Salta S, Bravo J, Silva A, Summavielle T. Acetyl-L-Carnitine Prevents Methamphetamine-Induced Structural Damage on Endothelial Cells via ILK-Related MMP-9 Activity. Mol Neurobiol. 2016;53:408-422 pubmed publisher
  190. Tang E, Mok K, Lee W, Cheng C. EB1 regulates tubulin and actin cytoskeletal networks at the sertoli cell blood-testis barrier in male rats: an in vitro study. Endocrinology. 2015;156:680-93 pubmed publisher
  191. Shirasago Y, Sekizuka T, Saito K, Suzuki T, Wakita T, Hanada K, et al. Isolation and characterization of an Huh.7.5.1-derived cell clone highly permissive to hepatitis C virus. Jpn J Infect Dis. 2015;68:81-8 pubmed publisher
  192. Wiechmann A, Ceresa B, Howard E. Diurnal variation of tight junction integrity associates inversely with matrix metalloproteinase expression in Xenopus laevis corneal epithelium: implications for circadian regulation of homeostatic surface cell desquamation. PLoS ONE. 2014;9:e113810 pubmed publisher
  193. Braniste V, Al Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6:263ra158 pubmed publisher
  194. Lei Q, Qiang F, Chao D, Di W, Guoqian Z, Bo Y, et al. Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1α signaling pathways. Int J Mol Med. 2014;34:1629-39 pubmed publisher
  195. Casselbrant A, Elias E, Fändriks L, Wallenius V. Expression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2015;11:45-53 pubmed publisher
  196. Tao S, Duanmu Y, Dong H, Tian J, Ni Y, Zhao R. A high-concentrate diet induced colonic epithelial barrier disruption is associated with the activating of cell apoptosis in lactating goats. BMC Vet Res. 2014;10:235 pubmed publisher
  197. Wögenstein K, Szabo S, Lunova M, Wiche G, Haybaeck J, Strnad P, et al. Epiplakin deficiency aggravates murine caerulein-induced acute pancreatitis and favors the formation of acinar keratin granules. PLoS ONE. 2014;9:e108323 pubmed publisher
  198. Kelsey L, Katoch P, Ray A, Mitra S, Chakraborty S, Lin M, et al. Vitamin D3 regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. PLoS ONE. 2014;9:e106437 pubmed publisher
  199. Gumber S, Nusrat A, Villinger F. Immunohistological characterization of intercellular junction proteins in rhesus macaque intestine. Exp Toxicol Pathol. 2014;66:437-44 pubmed publisher
  200. Kreft M, Jerman U, Lasič E, Lanišnik Rižner T, Hevir Kene N, Peternel L, et al. The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model. Pharm Res. 2015;32:665-79 pubmed publisher
  201. Bankwitz D, Vieyres G, Hueging K, Bitzegeio J, Doepke M, Chhatwal P, et al. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins. J Virol. 2014;88:12644-55 pubmed publisher
  202. Ragupathy S, Esmaeili F, Paschoud S, Sublet E, Citi S, Borchard G. Toll-like receptor 2 regulates the barrier function of human bronchial epithelial monolayers through atypical protein kinase C zeta, and an increase in expression of claudin-1. Tissue Barriers. 2014;2:e29166 pubmed publisher
  203. Crespi A, Bertoni A, Ferrari I, Padovano V, Della Mina P, Berti E, et al. POF1B localizes to desmosomes and regulates cell adhesion in human intestinal and keratinocyte cell lines. J Invest Dermatol. 2015;135:192-201 pubmed publisher
  204. Tawfik A, Markand S, Al Shabrawey M, Mayo J, Reynolds J, Bearden S, et al. Alterations of retinal vasculature in cystathionine-?-synthase heterozygous mice: a model of mild to moderate hyperhomocysteinemia. Am J Pathol. 2014;184:2573-85 pubmed publisher
  205. Jakimovski D, Schneider H, Frei K, Kennes L, Bertalanffy H. Bleeding propensity of cavernous malformations: impact of tight junction alterations on the occurrence of overt hematoma. J Neurosurg. 2014;121:613-20 pubmed publisher
  206. Benoit B, Plaisancie P, Geloen A, Estienne M, Debard C, Meugnier E, et al. Pasture v. standard dairy cream in high-fat diet-fed mice: improved metabolic outcomes and stronger intestinal barrier. Br J Nutr. 2014;112:520-35 pubmed publisher
  207. Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H, Steiner S, et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol. 2014;15:676-86 pubmed publisher
  208. Altshuler A, Lamadrid I, Li D, Ma S, Kurre L, Schmid Schonbein G, et al. Transmural intestinal wall permeability in severe ischemia after enteral protease inhibition. PLoS ONE. 2014;9:e96655 pubmed publisher
  209. Grosse B, Degrouard J, Jaillard D, Cassio D. Build them up and break them down: Tight junctions of cell lines expressing typical hepatocyte polarity with a varied repertoire of claudins. Tissue Barriers. 2013;1:e25210 pubmed publisher
  210. Reaves D, Fagan Solis K, Dunphy K, Oliver S, Scott D, Fleming J. The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior. PLoS ONE. 2014;9:e91747 pubmed publisher
  211. Yang D, Zuo C, Wang X, Meng X, Xue B, Liu N, et al. Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line. Proc Natl Acad Sci U S A. 2014;111:E1264-73 pubmed publisher
  212. Retana C, Sanchez E, Perez Lopez A, Cruz A, Lagunas J, Cruz C, et al. Alterations of intercellular junctions in peritoneal mesothelial cells from patients undergoing dialysis: effect of retinoic Acid. Perit Dial Int. 2015;35:275-87 pubmed publisher
  213. Wang S, Liu S, Mao J, Wen D. Effect of retinoic acid on the tight junctions of the retinal pigment epithelium-choroid complex of guinea pigs with lens-induced myopia in vivo. Int J Mol Med. 2014;33:825-32 pubmed publisher
  214. Xiao W, Feng Y, Holst J, Hartmann B, Yang H, Teitelbaum D. Glutamate prevents intestinal atrophy via luminal nutrient sensing in a mouse model of total parenteral nutrition. FASEB J. 2014;28:2073-87 pubmed publisher
  215. Fiorentino M, Levine M, Sztein M, Fasano A. Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release. PLoS ONE. 2014;9:e85211 pubmed publisher
  216. Boyer Di Ponio J, El Ayoubi F, Glacial F, Ganeshamoorthy K, Driancourt C, Godet M, et al. Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes. PLoS ONE. 2014;9:e84179 pubmed publisher
  217. Altshuler A, Richter M, Modestino A, Penn A, Heller M, Schmid Schonbein G. Removal of luminal content protects the small intestine during hemorrhagic shock but is not sufficient to prevent lung injury. Physiol Rep. 2013;1:e00109 pubmed publisher
  218. Jesus P, Ouelaa W, François M, Riachy L, Guérin C, Aziz M, et al. Alteration of intestinal barrier function during activity-based anorexia in mice. Clin Nutr. 2014;33:1046-53 pubmed publisher
  219. Zhang S, Liu Z, Heldsinger A, Owyang C, Yu S. Intraluminal acid activates esophageal nodose C fibers after mast cell activation. Am J Physiol Gastrointest Liver Physiol. 2014;306:G200-7 pubmed publisher
  220. Rincon Heredia R, Flores Benitez D, Flores Maldonado C, Bonilla Delgado J, García Hernández V, Verdejo Torres O, et al. Ouabain induces endocytosis and degradation of tight junction proteins through ERK1/2-dependent pathways. Exp Cell Res. 2014;320:108-18 pubmed publisher
  221. Sugimoto K, Ichikawa Tomikawa N, Satohisa S, Akashi Y, Kanai R, Saito T, et al. The tight-junction protein claudin-6 induces epithelial differentiation from mouse F9 and embryonic stem cells. PLoS ONE. 2013;8:e75106 pubmed publisher
  222. Hernández Monge J, Garay E, Raya Sandino A, Vargas Sierra O, Diaz Chavez J, Popoca Cuaya M, et al. Papillomavirus E6 oncoprotein up-regulates occludin and ZO-2 expression in ovariectomized mice epidermis. Exp Cell Res. 2013;319:2588-603 pubmed publisher
  223. Hirashima T, Hosokawa Y, Iino T, Nagayama M. On fundamental cellular processes for emergence of collective epithelial movement. Biol Open. 2013;2:660-6 pubmed publisher
  224. Someya M, Kojima T, Ogawa M, Ninomiya T, Nomura K, Takasawa A, et al. Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano. Cell Tissue Res. 2013;354:481-94 pubmed publisher
  225. Soscia D, Sequeira S, Schramm R, Jayarathanam K, Cantara S, Larsen M, et al. Salivary gland cell differentiation and organization on micropatterned PLGA nanofiber craters. Biomaterials. 2013;34:6773-84 pubmed publisher
  226. Watson P, Paterson J, Thom G, Ginman U, Lundquist S, Webster C. Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier. BMC Neurosci. 2013;14:59 pubmed publisher
  227. Liu Z, He J. Cell-cell contact-mediated hepatitis C virus (HCV) transfer, productive infection, and replication and their requirement for HCV receptors. J Virol. 2013;87:8545-58 pubmed publisher
  228. Cheng Y, Lan K, Lee W, Tseng S, Hung L, Lin H, et al. Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle. Clin Sci (Lond). 2013;125:439-48 pubmed publisher
  229. Szczepkowska A, Lagaraine C, Robert V, Dufourny L, Thiery J, Skipor J. Effect of a two-week treatment with a low dose of 2,2'4,4',5,5'-hexachlorobiphenyl (PCB153) on tight junction protein expression in ovine choroid plexus during long and short photoperiods. Neurotoxicol Teratol. 2013;37:63-7 pubmed publisher
  230. Sourisseau M, Michta M, Zony C, Israelow B, Hopcraft S, Narbus C, et al. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies. PLoS Pathog. 2013;9:e1003244 pubmed publisher
  231. Mishra R, Singh S. HIV-1 Tat C modulates expression of miRNA-101 to suppress VE-cadherin in human brain microvascular endothelial cells. J Neurosci. 2013;33:5992-6000 pubmed publisher
  232. Fiorentino M, Lammers K, Levine M, Sztein M, Fasano A. In vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid Vaccines. Front Immunol. 2013;4:17 pubmed publisher
  233. Kirschner N, Rosenthal R, Furuse M, Moll I, Fromm M, Brandner J. Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes. J Invest Dermatol. 2013;133:1161-9 pubmed publisher
  234. Kyuno D, Kojima T, Yamaguchi H, Ito T, Kimura Y, Imamura M, et al. Protein kinase C? inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pancreatic cancer. Carcinogenesis. 2013;34:1232-43 pubmed publisher
  235. Kim S, Ishida H, Yamane D, Yi M, Swinney D, Foung S, et al. Contrasting roles of mitogen-activated protein kinases in cellular entry and replication of hepatitis C virus: MKNK1 facilitates cell entry. J Virol. 2013;87:4214-24 pubmed publisher
  236. Kissoon Singh V, Moreau F, Trusevych E, Chadee K. Entamoeba histolytica exacerbates epithelial tight junction permeability and proinflammatory responses in Muc2(-/-) mice. Am J Pathol. 2013;182:852-65 pubmed publisher
  237. Stenman L, Holma R, Eggert A, Korpela R. A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids. Am J Physiol Gastrointest Liver Physiol. 2013;304:G227-34 pubmed publisher
  238. Takasawa A, Kojima T, Ninomiya T, Tsujiwaki M, Murata M, Tanaka S, et al. Behavior of tricellulin during destruction and formation of tight junctions under various extracellular calcium conditions. Cell Tissue Res. 2013;351:73-84 pubmed publisher
  239. Cheung T, Ganatra M, Peters E, Truskey G. Effect of cellular senescence on the albumin permeability of blood-derived endothelial cells. Am J Physiol Heart Circ Physiol. 2012;303:H1374-83 pubmed publisher
  240. Wang J, Novak I. Ion transport in human pancreatic duct epithelium, Capan-1 cells, is regulated by secretin, VIP, acetylcholine, and purinergic receptors. Pancreas. 2013;42:452-60 pubmed publisher
  241. Cantara S, Soscia D, Sequeira S, Jean Gilles R, Castracane J, Larsen M. Selective functionalization of nanofiber scaffolds to regulate salivary gland epithelial cell proliferation and polarity. Biomaterials. 2012;33:8372-82 pubmed publisher
  242. Baek H, Noh Y, Lee J, Yeon S, Jeong J, Kwon H. Autonomous isolation, long-term culture and differentiation potential of adult salivary gland-derived stem/progenitor cells. J Tissue Eng Regen Med. 2014;8:717-27 pubmed publisher
  243. Sandmann L, Wilson M, Back D, Wedemeyer H, Manns M, Steinmann E, et al. Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro. Antiviral Res. 2012;96:51-8 pubmed publisher
  244. Northrop N, Yamamoto B. Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier. J Neuroimmune Pharmacol. 2012;7:951-68 pubmed publisher
  245. Ji K, Tsirka S. Inflammation modulates expression of laminin in the central nervous system following ischemic injury. J Neuroinflammation. 2012;9:159 pubmed publisher
  246. Morel A, Hinkal G, Thomas C, Fauvet F, Courtois Cox S, Wierinckx A, et al. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS Genet. 2012;8:e1002723 pubmed publisher
  247. Guzman Aranguez A, Woodward A, Pintor J, ARGUESO P. Targeted disruption of core 1 ?1,3-galactosyltransferase (C1galt1) induces apical endocytic trafficking in human corneal keratinocytes. PLoS ONE. 2012;7:e36628 pubmed publisher
  248. Rittner H, Amasheh S, Moshourab R, Hackel D, Yamdeu R, Mousa S, et al. Modulation of tight junction proteins in the perineurium to facilitate peripheral opioid analgesia. Anesthesiology. 2012;116:1323-34 pubmed publisher
  249. Kelsey L, Katoch P, Johnson K, Batra S, Mehta P. Retinoids regulate the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. PLoS ONE. 2012;7:e32846 pubmed publisher
  250. Géraud C, Evdokimov K, Straub B, Peitsch W, Demory A, Dörflinger Y, et al. Unique cell type-specific junctional complexes in vascular endothelium of human and rat liver sinusoids. PLoS ONE. 2012;7:e34206 pubmed publisher
  251. Jiang X, Guo M, Su J, Lu B, Ma D, Zhang R, et al. Simvastatin blocks blood-brain barrier disruptions induced by elevated cholesterol both in vivo and in vitro. Int J Alzheimers Dis. 2012;2012:109324 pubmed publisher
  252. Hsieh J, Lu C, Huang C, Shieh G, Su B, Su Y, et al. Acquisition of an enhanced aggressive phenotype in human lung cancer cells selected by suboptimal doses of cisplatin following cell deattachment and reattachment. Cancer Lett. 2012;321:36-44 pubmed publisher
  253. Ritchie J, Rui H, Zhou X, Iida T, Kodoma T, Ito S, et al. Inflammation and disintegration of intestinal villi in an experimental model for Vibrio parahaemolyticus-induced diarrhea. PLoS Pathog. 2012;8:e1002593 pubmed publisher
  254. Dukes J, Whitley P, Chalmers A. The PIKfyve inhibitor YM201636 blocks the continuous recycling of the tight junction proteins claudin-1 and claudin-2 in MDCK cells. PLoS ONE. 2012;7:e28659 pubmed publisher
  255. Korompay A, Borka K, Lotz G, Somorácz A, Törzsök P, Erdélyi Belle B, et al. Tricellulin expression in normal and neoplastic human pancreas. Histopathology. 2012;60:E76-86 pubmed publisher
  256. Fernandes I, de Freitas V, Reis C, Mateus N. A new approach on the gastric absorption of anthocyanins. Food Funct. 2012;3:508-16 pubmed publisher
  257. Kyuno D, Kojima T, Ito T, Yamaguchi H, Tsujiwaki M, Takasawa A, et al. Protein kinase C? inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4. Cell Tissue Res. 2011;346:369-81 pubmed publisher
  258. Nguyen Hoang A, Chen P, Juarez J, Sachamitr P, Billing B, Bosnjak L, et al. Dendritic cell functional properties in a three-dimensional tissue model of human lung mucosa. Am J Physiol Lung Cell Mol Physiol. 2012;302:L226-37 pubmed publisher
  259. Lan K, Wang Y, Lee W, Lan K, Tseng S, Hung L, et al. Multiple effects of Honokiol on the life cycle of hepatitis C virus. Liver Int. 2012;32:989-97 pubmed publisher
  260. Lee S, Shin J, Kwon H, Weiner I, Han K. Renal ischemia-reperfusion injury causes intercalated cell-specific disruption of occludin in the collecting duct. Histochem Cell Biol. 2011;136:637-47 pubmed publisher
  261. Chi F, Wang L, Zheng X, Wu C, Jong A, Sheard M, et al. Meningitic Escherichia coli K1 penetration and neutrophil transmigration across the blood-brain barrier are modulated by alpha7 nicotinic receptor. PLoS ONE. 2011;6:e25016 pubmed publisher
  262. Carman A, Mills J, Krenz A, Kim D, Bynoe M. Adenosine receptor signaling modulates permeability of the blood-brain barrier. J Neurosci. 2011;31:13272-80 pubmed publisher
  263. Lubarski I, Asher C, Garty H. FXYD5 (dysadherin) regulates the paracellular permeability in cultured kidney collecting duct cells. Am J Physiol Renal Physiol. 2011;301:F1270-80 pubmed publisher
  264. Quaranta M, Vincentini O, Felli C, Spadaro F, Silano M, Moricoli D, et al. Exogenous HIV-1 Nef upsets the IFN-?-induced impairment of human intestinal epithelial integrity. PLoS ONE. 2011;6:e23442 pubmed publisher
  265. Humen M, Perez P, Liévin Le Moal V. Lipid raft-dependent adhesion of Giardia intestinalis trophozoites to a cultured human enterocyte-like Caco-2/TC7 cell monolayer leads to cytoskeleton-dependent functional injuries. Cell Microbiol. 2011;13:1683-702 pubmed publisher
  266. Kojima T, Takasawa A, Kyuno D, Ito T, Yamaguchi H, Hirata K, et al. Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human pancreatic cancer cells. Exp Cell Res. 2011;317:2288-98 pubmed publisher
  267. Dukes J, Fish L, Richardson J, Blaikley E, Burns S, Caunt C, et al. Functional ESCRT machinery is required for constitutive recycling of claudin-1 and maintenance of polarity in vertebrate epithelial cells. Mol Biol Cell. 2011;22:3192-205 pubmed publisher
  268. Belgiovine C, Chiodi I, Mondello C. Relocalization of cell adhesion molecules during neoplastic transformation of human fibroblasts. Int J Oncol. 2011;39:1199-204 pubmed publisher
  269. Jahn K, Biazik J, Braet F. GM1 expression in caco-2 cells: characterisation of a fundamental passage-dependent transformation of a cell line. J Pharm Sci. 2011;100:3751-62 pubmed publisher
  270. Ciesek S, Westhaus S, Wicht M, Wappler I, Henschen S, Sarrazin C, et al. Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles. J Virol. 2011;85:7613-21 pubmed publisher
  271. Yan J, Zhang Z, Shi H. HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells. Cell Mol Life Sci. 2012;69:115-28 pubmed publisher
  272. Lagaraine C, Skipor J, Szczepkowska A, Dufourny L, Thiery J. Tight junction proteins vary in the choroid plexus of ewes according to photoperiod. Brain Res. 2011;1393:44-51 pubmed publisher
  273. Kwon Y, Cukierman E, Godwin A. Differential expressions of adhesive molecules and proteases define mechanisms of ovarian tumor cell matrix penetration/invasion. PLoS ONE. 2011;6:e18872 pubmed publisher
  274. Butt O, Buehler P, D Agnillo F. Blood-brain barrier disruption and oxidative stress in guinea pig after systemic exposure to modified cell-free hemoglobin. Am J Pathol. 2011;178:1316-28 pubmed publisher
  275. Kirschner N, Haftek M, Niessen C, Behne M, Furuse M, Moll I, et al. CD44 regulates tight-junction assembly and barrier function. J Invest Dermatol. 2011;131:932-43 pubmed publisher
  276. De Benedetto A, Rafaels N, McGirt L, Ivanov A, Georas S, Cheadle C, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127:773-86.e1-7 pubmed publisher
  277. Haarmann A, Deiss A, Prochaska J, Foerch C, Weksler B, Romero I, et al. Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown. PLoS ONE. 2010;5:e13568 pubmed publisher
  278. Eyre N, Drummer H, Beard M. The SR-BI partner PDZK1 facilitates hepatitis C virus entry. PLoS Pathog. 2010;6:e1001130 pubmed publisher
  279. Govindarajan R, Chakraborty S, Johnson K, Falk M, Wheelock M, Johnson K, et al. Assembly of connexin43 into gap junctions is regulated differentially by E-cadherin and N-cadherin in rat liver epithelial cells. Mol Biol Cell. 2010;21:4089-107 pubmed publisher
  280. Su L, Mruk D, Lee W, Cheng C. Differential effects of testosterone and TGF-?3 on endocytic vesicle-mediated protein trafficking events at the blood-testis barrier. Exp Cell Res. 2010;316:2945-60 pubmed publisher
  281. Cong W, Hirose T, Harita Y, Yamashita A, Mizuno K, Hirano H, et al. ASPP2 regulates epithelial cell polarity through the PAR complex. Curr Biol. 2010;20:1408-14 pubmed publisher
  282. Burgel B, Friesland M, Koch A, Manns M, Wedemeyer H, Weissenborn K, et al. Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration. J Viral Hepat. 2011;18:562-70 pubmed publisher
  283. Yamaguchi H, Kojima T, Ito T, Kimura Y, Imamura M, Son S, et al. Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells. Am J Pathol. 2010;177:698-712 pubmed publisher
  284. Garay E, Patino Lopez G, Islas S, Alarcón L, Canche Pool E, Valle Rios R, et al. CRTAM: A molecule involved in epithelial cell adhesion. J Cell Biochem. 2010;111:111-22 pubmed publisher
  285. Kojima T, Fuchimoto J, Yamaguchi H, Ito T, Takasawa A, Ninomiya T, et al. c-Jun N-terminal kinase is largely involved in the regulation of tricellular tight junctions via tricellulin in human pancreatic duct epithelial cells. J Cell Physiol. 2010;225:720-33 pubmed publisher
  286. De la Serre C, Ellis C, Lee J, Hartman A, Rutledge J, Raybould H. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 2010;299:G440-8 pubmed publisher
  287. Schubert Unkmeir A, Konrad C, Slanina H, Czapek F, Hebling S, Frosch M. Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8. PLoS Pathog. 2010;6:e1000874 pubmed publisher
  288. Yakovich A, Huang Q, Du J, Jiang B, Barnard J. Vectorial TGFbeta signaling in polarized intestinal epithelial cells. J Cell Physiol. 2010;224:398-404 pubmed publisher
  289. Ciesek S, Steinmann E, Iken M, Ott M, Helfritz F, Wappler I, et al. Glucocorticosteroids increase cell entry by hepatitis C virus. Gastroenterology. 2010;138:1875-84 pubmed publisher
  290. Ploss A, Khetani S, Jones C, Syder A, Trehan K, Gaysinskaya V, et al. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A. 2010;107:3141-5 pubmed publisher
  291. Karim M, Biswas S, Bhattacherjee P, Paterson C. Comparison of tight junction protein expression in the ciliary epithelia of mouse, rabbit, cat and human eyes. Biotech Histochem. 2011;86:161-7 pubmed publisher
  292. Chakraborty S, Mitra S, Falk M, Caplan S, Wheelock M, Johnson K, et al. E-cadherin differentially regulates the assembly of Connexin43 and Connexin32 into gap junctions in human squamous carcinoma cells. J Biol Chem. 2010;285:10761-76 pubmed publisher
  293. Ohkuni T, Kojima T, Ogasawara N, Masaki T, Ninomiya T, Kikuchi S, et al. Expression and localization of tricellulin in human nasal epithelial cells in vivo and in vitro. Med Mol Morphol. 2009;42:204-11 pubmed publisher
  294. Joannes A, Bonnomet A, Bindels S, Polette M, Gilles C, Burlet H, et al. Fhit regulates invasion of lung tumor cells. Oncogene. 2010;29:1203-13 pubmed publisher
  295. Sadowska G, Malaeb S, Stonestreet B. Maternal glucocorticoid exposure alters tight junction protein expression in the brain of fetal sheep. Am J Physiol Heart Circ Physiol. 2010;298:H179-88 pubmed publisher
  296. Kamekura R, Kojima T, Koizumi J, Ogasawara N, Kurose M, Go M, et al. Thymic stromal lymphopoietin enhances tight-junction barrier function of human nasal epithelial cells. Cell Tissue Res. 2009;338:283-93 pubmed publisher
  297. Shimazaki J, Higa K, Kato N, Satake Y. Barrier function of cultivated limbal and oral mucosal epithelial cell sheets. Invest Ophthalmol Vis Sci. 2009;50:5672-80 pubmed publisher
  298. Matsumoto M, Oyamada K, Takahashi H, Sato T, Hatakeyama S, Nakayama K. Large-scale proteomic analysis of tyrosine-phosphorylation induced by T-cell receptor or B-cell receptor activation reveals new signaling pathways. Proteomics. 2009;9:3549-63 pubmed publisher
  299. Nicholson M, Lindsay L, Murphy C. Ovarian hormones control the changing expression of claudins and occludin in rat uterine epithelial cells during early pregnancy. Acta Histochem. 2010;112:42-52 pubmed publisher
  300. Sobarzo C, Lustig L, Ponzio R, Suescun M, Denduchis B. Effects of di(2-ethylhexyl) phthalate on gap and tight junction protein expression in the testis of prepubertal rats. Microsc Res Tech. 2009;72:868-77 pubmed publisher
  301. Waldow T, Witt W, Janke A, Ulmer A, Buzin A, Matschke K. Cell-cell junctions and vascular endothelial growth factor in rat lung as affected by ischemia/reperfusion and preconditioning with inhaled nitric oxide. J Surg Res. 2009;157:30-42 pubmed publisher
  302. Murakami T, Felinski E, Antonetti D. Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem. 2009;284:21036-46 pubmed publisher
  303. McCaffrey G, Willis C, Staatz W, Nametz N, Quigley C, Hom S, et al. Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. J Neurochem. 2009;110:58-71 pubmed publisher
  304. Alanne M, Pummi K, Heape A, Grenman R, Peltonen J, Peltonen S. Tight junction proteins in human Schwann cell autotypic junctions. J Histochem Cytochem. 2009;57:523-9 pubmed publisher
  305. Tian J, Hao L, Chandra P, Jones D, Willams I, Gewirtz A, et al. Dietary glutamine and oral antibiotics each improve indexes of gut barrier function in rat short bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2009;296:G348-55 pubmed publisher
  306. Son S, Kojima T, Decaens C, Yamaguchi H, Ito T, Imamura M, et al. Knockdown of tight junction protein claudin-2 prevents bile canalicular formation in WIF-B9 cells. Histochem Cell Biol. 2009;131:411-24 pubmed publisher
  307. McLaughlin J, Lambert D, Padfield P, Burt J, O Neill C. The mycotoxin patulin, modulates tight junctions in caco-2 cells. Toxicol In Vitro. 2009;23:83-9 pubmed publisher
  308. Sugimoto M, Inoko A, Shiromizu T, Nakayama M, Zou P, Yonemura S, et al. The keratin-binding protein Albatross regulates polarization of epithelial cells. J Cell Biol. 2008;183:19-28 pubmed publisher
  309. Hemphill A, Vonlaufen N, Golaz J, Burgener I. Infection of primary canine duodenal epithelial cell cultures with Neospora caninum. J Parasitol. 2009;95:372-80 pubmed publisher
  310. Neuhaus W, Wirth M, Plattner V, Germann B, Gabor F, Noe C. Expression of Claudin-1, Claudin-3 and Claudin-5 in human blood-brain barrier mimicking cell line ECV304 is inducible by glioma-conditioned media. Neurosci Lett. 2008;446:59-64 pubmed publisher
  311. Chen X, Lan X, Roche I, Liu R, Geiger J. Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J Neurochem. 2008;107:1147-57 pubmed publisher
  312. Van Hoof D, Braam S, Dormeyer W, Ward van Oostwaard D, Heck A, Krijgsveld J, et al. Feeder-free monolayer cultures of human embryonic stem cells express an epithelial plasma membrane protein profile. Stem Cells. 2008;26:2777-81 pubmed publisher
  313. McCaffrey G, Seelbach M, Staatz W, Nametz N, Quigley C, Campos C, et al. Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia. J Neurochem. 2008;106:2395-409 pubmed publisher
  314. Bouschbacher M, Bomsel M, Verronèse E, Gofflo S, Ganor Y, Dezutter Dambuyant C, et al. Early events in HIV transmission through a human reconstructed vaginal mucosa. AIDS. 2008;22:1257-66 pubmed publisher
  315. Neuhaus W, Plattner V, Wirth M, Germann B, Lachmann B, Gabor F, et al. Validation of in vitro cell culture models of the blood-brain barrier: tightness characterization of two promising cell lines. J Pharm Sci. 2008;97:5158-75 pubmed publisher
  316. Chen X, Gawryluk J, Wagener J, Ghribi O, Geiger J. Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J Neuroinflammation. 2008;5:12 pubmed publisher
  317. Takano K, Kojima T, Ogasawara N, Go M, Kikuchi S, Ninomiya T, et al. Expression of tight junction proteins in epithelium including Ck20-positive M-like cells of human adenoids in vivo and in vitro. J Mol Histol. 2008;39:265-73 pubmed publisher
  318. Paschoud S, Citi S. Inducible overexpression of cingulin in stably transfected MDCK cells does not affect tight junction organization and gene expression. Mol Membr Biol. 2008;25:1-13 pubmed
  319. Lussier C, Babeu J, Auclair B, Perreault N, Boudreau F. Hepatocyte nuclear factor-4alpha promotes differentiation of intestinal epithelial cells in a coculture system. Am J Physiol Gastrointest Liver Physiol. 2008;294:G418-28 pubmed
  320. Kojima T, Takano K, Yamamoto T, Murata M, Son S, Imamura M, et al. Transforming growth factor-beta induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes. Liver Int. 2008;28:534-45 pubmed
  321. McCaffrey G, Staatz W, Quigley C, Nametz N, Seelbach M, Campos C, et al. Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. J Neurochem. 2007;103:2540-55 pubmed publisher
  322. Ohnemus U, Kohrmeyer K, Houdek P, Rohde H, Wladykowski E, Vidal S, et al. Regulation of epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains. J Invest Dermatol. 2008;128:906-16 pubmed
  323. Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 2007;204:2349-62 pubmed
  324. Dhasarathy A, Kajita M, Wade P. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol Endocrinol. 2007;21:2907-18 pubmed
  325. Mandell K, Berglin L, Severson E, Edelhauser H, Parkos C. Expression of JAM-A in the human corneal endothelium and retinal pigment epithelium: localization and evidence for role in barrier function. Invest Ophthalmol Vis Sci. 2007;48:3928-36 pubmed
  326. Moser L, Carter M, Schultz Cherry S. Astrovirus increases epithelial barrier permeability independently of viral replication. J Virol. 2007;81:11937-45 pubmed
  327. Golaz J, Vonlaufen N, Hemphill A, Burgener I. Establishment and characterization of a primary canine duodenal epithelial cell culture. In Vitro Cell Dev Biol Anim. 2007;43:176-85 pubmed
  328. Morgan L, Shah B, Rivers L, Barden L, Groom A, Chung R, et al. Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis. Neuroscience. 2007;147:664-73 pubmed
  329. Beau I, Cotte Laffitte J, Amsellem R, Servin A. A protein kinase A-dependent mechanism by which rotavirus affects the distribution and mRNA level of the functional tight junction-associated protein, occludin, in human differentiated intestinal Caco-2 cells. J Virol. 2007;81:8579-86 pubmed
  330. Hernandez S, Chavez Munguia B, Gonzalez Mariscal L. ZO-2 silencing in epithelial cells perturbs the gate and fence function of tight junctions and leads to an atypical monolayer architecture. Exp Cell Res. 2007;313:1533-47 pubmed
  331. Stucke V, Timmerman E, Vandekerckhove J, Gevaert K, Hall A. The MAGUK protein MPP7 binds to the polarity protein hDlg1 and facilitates epithelial tight junction formation. Mol Biol Cell. 2007;18:1744-55 pubmed
  332. Mitra S, Annamalai L, Chakraborty S, Johnson K, Song X, Batra S, et al. Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. Mol Biol Cell. 2006;17:5400-16 pubmed
  333. Anstrom J, Thore C, Moody D, Brown W. Immunolocalization of tight junction proteins in blood vessels in human germinal matrix and cortex. Histochem Cell Biol. 2007;127:205-13 pubmed
  334. Uchino Y, Shimmura S, Miyashita H, Taguchi T, Kobayashi H, Shimazaki J, et al. Amniotic membrane immobilized poly(vinyl alcohol) hybrid polymer as an artificial cornea scaffold that supports a stratified and differentiated corneal epithelium. J Biomed Mater Res B Appl Biomater. 2007;81:201-6 pubmed
  335. Larre I, Ponce A, Fiorentino R, Shoshani L, Contreras R, Cereijido M. Contacts and cooperation between cells depend on the hormone ouabain. Proc Natl Acad Sci U S A. 2006;103:10911-6 pubmed
  336. Herouy Y, Kahle B, Idzko M, Eberth I, Norgauer J, Pannier F, et al. Tight junctions and compression therapy in chronic venous insufficiency. Int J Mol Med. 2006;18:215-9 pubmed
  337. Gonzalez Mariscal L, Namorado M, Martin D, Sierra G, Reyes J. The tight junction proteins claudin-7 and -8 display a different subcellular localization at Henle's loops and collecting ducts of rabbit kidney. Nephrol Dial Transplant. 2006;21:2391-8 pubmed
  338. Watson C, Hoare C, Garrod D, Carlson G, Warhurst G. Interferon-gamma selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores. J Cell Sci. 2005;118:5221-30 pubmed
  339. Zhu L, Li X, Zeng R, Gorodeski G. Changes in tight junctional resistance of the cervical epithelium are associated with modulation of content and phosphorylation of occludin 65-kilodalton and 50-kilodalton forms. Endocrinology. 2006;147:977-89 pubmed
  340. Schierack P, Nordhoff M, Pollmann M, Weyrauch K, Amasheh S, Lodemann U, et al. Characterization of a porcine intestinal epithelial cell line for in vitro studies of microbial pathogenesis in swine. Histochem Cell Biol. 2006;125:293-305 pubmed
  341. Miyashita H, Shimmura S, Kobayashi H, Taguchi T, Asano Kato N, Uchino Y, et al. Collagen-immobilized poly(vinyl alcohol) as an artificial cornea scaffold that supports a stratified corneal epithelium. J Biomed Mater Res B Appl Biomater. 2006;76:56-63 pubmed
  342. Haton C, Lebrun F, Benderitter M, Griffiths N. Maintenance of differentiation capacity of HT-29 cells after radiation exposure. Int J Radiat Biol. 2005;81:211-20 pubmed
  343. Clark E, Hoare C, Tanianis Hughes J, Carlson G, Warhurst G. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology. 2005;128:1258-67 pubmed
  344. Bordin M, D Atri F, Guillemot L, Citi S. Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. Mol Cancer Res. 2004;2:692-701 pubmed
  345. Go M, Kojima T, Takano K, Murata M, Ichimiya S, Tsubota H, et al. Expression and function of tight junctions in the crypt epithelium of human palatine tonsils. J Histochem Cytochem. 2004;52:1627-38 pubmed
  346. Somosy Z, Forgacs Z, Bognár G, Horvath K, Horváth G. Alteration of tight and adherens junctions on 50-Hz magnetic field exposure in Madin Darby canine kidney (MDCK) cells. ScientificWorldJournal. 2004;4 Suppl 2:75-82 pubmed
  347. Zeng R, Li X, Gorodeski G. Estrogen abrogates transcervical tight junctional resistance by acceleration of occludin modulation. J Clin Endocrinol Metab. 2004;89:5145-55 pubmed
  348. Sundberg U, Beauchemin N, Obrink B. The cytoplasmic domain of CEACAM1-L controls its lateral localization and the organization of desmosomes in polarized epithelial cells. J Cell Sci. 2004;117:1091-104 pubmed
  349. Kahle B, Idzko M, Norgauer J, Rabe E, Herouy Y. Tightening tight junctions with compression therapy. J Invest Dermatol. 2003;121:1228-9 pubmed
  350. Billings S, Walsh S, Fisher C, Nusrat A, Weiss S, Folpe A. Aberrant expression of tight junction-related proteins ZO-1, claudin-1 and occludin in synovial sarcoma: an immunohistochemical study with ultrastructural correlation. Mod Pathol. 2004;17:141-9 pubmed
  351. Malminen M, Koivukangas V, Peltonen J, Karvonen S, Oikarinen A, Peltonen S. Immunohistological distribution of the tight junction components ZO-1 and occludin in regenerating human epidermis. Br J Dermatol. 2003;149:255-60 pubmed
  352. Evans S, Blyth D, Wong T, Sanjar S, West M. Decreased distribution of lung epithelial junction proteins after intratracheal antigen or lipopolysaccharide challenge: correlation with neutrophil influx and levels of BALF sE-cadherin. Am J Respir Cell Mol Biol. 2002;27:446-54 pubmed
  353. Tavelin S, Gråsjö J, Taipalensuu J, Ocklind G, Artursson P. Applications of epithelial cell culture in studies of drug transport. Methods Mol Biol. 2002;188:233-72 pubmed
  354. Busch C, Hanssen T, Wagener C, Obrink B. Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum Pathol. 2002;33:290-8 pubmed
  355. Gudjonsson T, Villadsen R, Nielsen H, Rønnov Jessen L, Bissell M, Petersen O. Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev. 2002;16:693-706 pubmed
  356. Gudjonsson T, Rønnov Jessen L, Villadsen R, Rank F, Bissell M, Petersen O. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci. 2002;115:39-50 pubmed
  357. Pummi K, Malminen M, Aho H, Karvonen S, Peltonen J, Peltonen S. Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes. J Invest Dermatol. 2001;117:1050-8 pubmed